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Editor: D. BarceloThe evolution and impact of the published literature surrounding the transdisciplinary, multifaceted topic of
pharmaceuticals as contaminants in the environment is examined for the ﬁrst time in an historical context.
The preponderance of literature cited in this examination represents the earlier works. As an historical chronol-
ogy, the focus is on the emergence of key, speciﬁc aspects of the overall topic (often termed PiE) in the published
literature and on themost highly cited works. This examination is not a conventional, technical review of the lit-
erature; as such, little attention was devoted to the more recent literature.
Themany dimensions involvedwith PiE span over 70 years of published literature. Some articles began to appear
in published works in the 1940s and earlier, while others only began to receive attention in the 1990s and later.
Decades of early research onwhat at the time seemed to be disconnected topics eventually coalesced in themid-
to-late 1990s around a number of interconnected concerns and issues that now comprise PiE. Major objectives
are to provide a new perspective to the topic, to facilitate more efﬁcient and effective review of the literature
by others, and to recognize themore signiﬁcant, seminal contributions to the advancement of PiE as a ﬁeld of re-
search. Some of themost highly cited articles in all of environmental science now involve PiE. As of April 2015, aKeywords:
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392 C.G. Daughton / Science of the Total Environment 562 (2016) 391–426core group of 385 PiE articles had each received at least 200 citations; one had received 5424 citations. But hun-
dreds of additional articles also played important roles in the evolution and advancement of the ﬁeld.
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A perspective is presented on the early history surrounding the
evolution of the topic of pharmaceuticals as contaminants in the
environment. This perspective is derived from examining key words
and the metadata associated with a comprehensive database of articles
relevant to this multi-faceted topic. The articles in this database were
published in an array of resources, but primarily journals, books,
reports, and dissertations:
Daughton and Scuderi, 2016b “Pharmaceuticals and Personal Care
Products (PPCPs): Relevant Literature”.
[Note: the non-standard format used in this paper to cite references is
discussed at the end of Section 3 (Approach).]
The wide spectrum of issues surrounding this complex, multi-faceted
topic span over 70 years of published literature. Some articles began to
appear in published works in the 1940s and earlier. Other aspects did
not begin to receive attention until the 1990s and continuing to this
day. With decades of research on what at the time seemed to be discon-
nected topics, a discrete ﬁeld of research eventually coalesced in the
mid-1990s around a number of interconnected concerns and issues relat-
ed to the environmental occurrence of the active ingredients in drugs
(known as active pharmaceutical ingredients, APIs). Among a number
of terms used over the years, this ﬁeld of research is frequently referred
to as Pharmaceuticals in the Environment — often abbreviated PiE.This examination is not a review of the literature. It is not an
examination of the technical content of the PiE published literature
or an attempt to distill new knowledge regarding the PiE topic.
Rather, it began simply as an attempt to see whether new insights
might emerge when trying to examine from some new perspectives
a very large body of published literature surrounding a complex and
expansive facet of environmental science. While this examination of
PiE tries to show the historical trajectory of PiE and to place some
events in an historical context, it does not attempt to summarize or
critique what has been learned or to proffer where its future should
aim; as such, it is important to keep in mind that the focus is on the
older, pioneering literature rather than newer literature. To my
knowledge, such an assessment has not been attempted before —
nor has one been speciﬁcally called for. This effort was partly
motivated by the fact that PiE comprises an extremely large body
of disparate published literature, contributed from many different
and usually disconnected technical disciplines. At the least, this
examination tried to document some of the history behind the
evolution or emergence of PiE as a ﬁeld of study. As such, errors
and omissions are inevitable — sometimes casualties of the subjec-
tive nature of deﬁning the actual scope of PiE as a dedicated ﬁeld of
research.
This article could be partly viewed as an historical bibliometric
examination of PiE. Surprisingly, very few bibliometric examinations
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wastewater treatment and drinkingwater; they have also not examined
the literature prior to 1992. Here are two examples:
Fu et al., 2013 “Mapping of drinking water research: A bibliometric
analysis of research output during 1992–2011”.
Qian et al., 2015 “A bibliometric analysis of global research progress
on pharmaceutical wastewater treatment during 1994–2013”.
Many of the terms and concepts that have surrounded or intersected
with the PiE ﬁeld of research were examined with respect to their his-
torical emergence in the literature. Some large-scale bibliographic cita-
tion analysis was also performed to try and locate the most inﬂuential
journals, articles, and authors. Whether anything of use will emerge
from this journey can only be judged by the reader; this is especially
the case given the necessarily disjointed and uneven array of topics cov-
ered. But a working hypothesis could be whether it is important to as-
sess the evolution of a still-growing area of research that has emerged
over the course of decades. An obvious question, however, is whether
the sizeable investment in resources represented by this body of pub-
lished works has been most effectively allocated, whether it has been
overly redundant or unnecessarily incremental, and whether its data
and insights might be more effectively mined and organized to yield
useful new knowledge. Although some of the issues brieﬂy touched
upon here are germane to other topics or concerns in environmental
science, they either originated from PiE or intersect with PiE. Some is-
sues and concerns are unique to PiE, and others represent new areas
that have been catalyzed or fostered by PiE research.2. Scope of the PiE issue
In referring to “the environment”with respect to PiE, it must be em-
phasized that there are two dimensions that are often compartmental-
ized but which really form a continuum — the immediate, built
(human-made) environment and the so-called natural environment.
Drugs can have adverse – and sometimes profound – consequences
after entering either. Transit into the immediate, surroundingbuilt envi-
ronment involves short, direct upstream pathways that can result in
high exposure levels leading to acute – and sometimes fatal – toxicity
for exposed humans, domestic animals, and wildlife. These upstream
pathways involve imprudent storage and disposal practices for medica-
tions, as well as certain types of occupational practices such as those
resulting from insufﬁciently controlled pharmacy compounding of
highly toxic pharmaceuticals or from unprotected handling of contami-
nated laundry from those undergoing chemotherapy (Daughton and
Ruhoy, 2009 “Environmental footprint of pharmaceuticals: The
signiﬁcance of factors beyond direct excretion to sewers”). In contrast,
pathways leading to the natural environment involve downstream pro-
cesses such as the introduction of drug residues to surface or ground
waters via municipal or manufacturer wastewater discharge or from
landﬁlls. These downstream processes generally involve levels of expo-
sure to active pharmaceutical ingredients (APIs) that are orders of mag-
nitude lower than from upstream processes - often simply a result of
dilution.
It is important to recognize that these two major pathways are the
subjects of completely separate and distinct bodies of published
literature that rarely cross-reference each other. The former is largely
the domain of clinical medicine practitioners, toxicologists, and forensic
specialists while the latter involves a host of disciplines within the
environmental sciences. In reality, however, all of these processes and
types of exposure are interrelated and comprise a complex network
(see Fig. 1 in. Daughton, 2008 “Pharmaceuticals as environmental
pollutants: the ramiﬁcations for human exposure”) that reﬂects
society's widespread, multi-faceted relationship with the expansive
universe of therapeutic and lifestyle drugs, which comprises thousands
of distinct APIs formulated into tens of thousands of differentmedicated
products, as well as a largely separate galaxy of illicit drugs (see:Daughton, 2013 “Pharmaceuticals in the Environment: Sources and
Their Management”).
The persistent isolation of two distinct bodies of literature might
seem surprising since both play major roles in deﬁning the full scope
of PiE and in seeking solutions for reducing or preventing a ubiquitous
source of anthropogenic contamination of the environment. Drugs
have been widely known to be involved in accidental, unintentional
fatal human poisonings since the 1800s, with salicylates (particularly
methyl salicylate) playing a major role. Formal case reports were
being published as early as the 1930s; for example, see the references
cited in the following:
Davis, 2007 “Are one or two dangerous? Methyl salicylate exposure
in toddlers”.
Shirreff and Pearlman, 1940 “Oil of wintergreen poisoning: (Report
of Two Additional Fatal Cases)”.
Troll and Menten, 1945 “Salicylate poisoning: report of four cases”.
Hundreds of journal articles have been published since the 1940s on
the unintentional and accidental, acute poisonings of children (drugs
have long been a major cause of fatal poisonings among children) as a
result of improperly stored or discarded medications. Other types of
fatal poisonings from unintended exposures did not attract concerted
attention until decades later. Accidental poisonings of pets did not
begin attracting attention until the 1980s:
Fitzgerald et al., 2006 ““Over-The-Counter” Drug Toxicities in
Companion Animals”.
Murphy, 1994 “Toxin exposures in dogs and cats: drugs and
household products”.
Mass killings of raptors from scavenging improperly disposed
carcasses of animals that had been euthanized with barbiturates
began to attract attention in the 1990s:
Langelier, 1993 “Barbiturate poisoning in twenty-nine bald eagles”.
USFWS, 2003 “Pentobarbital Poisoning of Eagles”.
And the devastation of certain vulture populations from scavenging
carcasses of animals that had been therapeutically treated with certain
non-steroidal anti-inﬂammatories (notably diclofenac) emerged as a
major ecological concern in 2004:
Green et al., 2004 “Diclofenac poisoning as a cause of vulture
population declines across the Indian subcontinent”.
Oaks et al., 2004 “Diclofenac residues as the cause of vulture
population decline in Pakistan”.
Shultz et al., 2004 “Diclofenac poisoning is widespread in declining
vulture populations across the Indian subcontinent”.
With acute “upstream” poisonings aside, the major concerns with
regard to the presence of APIs in the environment result from chronic,
low-level exposures for a broad spectrum of organisms ranging from
microorganisms to mammalian wildlife. These downstream impacts
can be subtle (such as modiﬁcation to various behaviors), and their
overall signiﬁcance regarding species health at the population level con-
tinues to be scrutinized. Also important to note is that the issues sur-
rounding APIs in the environment are closely intertwined with those
involving other commonly used consumer chemicals, especially the
myriad numbers of personal care products, nutritional supplements,
and ever-expanding universe of illicit drugs - all of which may partici-
pate in complex interactions with biological receptors.
3. Approach
This examination of the published literature – covering all facets of
pharmaceuticals in relationship to the environment – relied on a spe-
cialized, curated bibliographic database that houses the digitized full
text for over 97% of the journal articles it contains (Daughton and
Scuderi, 2016b “Pharmaceuticals and Personal Care Products (PPCPs):
Relevant Literature”). Two different versions of the database are avail-
able to the public — a simple text listing of the bibliographic citations
or an electronic database version of the citations together with
abstracts; because of publisher copyright restrictions, the complete
Table 1
Numbers of articles relevant to PiE in journals and books from 1980 to 2015.a
Decade or year Number of articles Percent increase
1980–1989 85 Percent increase over prior decade
1990–1999 500 488
2000–2009 5458 992
2010–2014 7308 (Half decade) 33.9
2000 181 Percent increase over prior year
2001 207 14.4
2002 242 16.9
2003 335 38.4
2004 421 25.7
2005 512 21.6
2006 697 36.1
2007 827 18.7
2008 925 11.9
2009 1111 20.1
2010 1146 3.2
2011 1184 3.3
2012 1541 30.2
2013 1635 6.1
2014 1802 10.2
2015 1524 Incomplete year (through 6 August 2015)
a Data compiled up until 6 August 2015.
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ployees. Background and history regarding the database are provided
here: https://sites.google.com/site/daughton/PPCPs-bibliographic_
database. As of 6 August 2015, it contained over 22,600 records — over
16,900 of which were journal articles and over 1100 were book chap-
ters. Only 14 (0.08%) of the nearly 17,000 journal articles had been
retracted or withdrawn — half of these by the same author. A total of
192 articles (1%) were published in journals that some deﬁne as “pred-
atory” (e.g., see: http://scholarlyoa.com/publishers/), while noting that
this can be a contentious issue and one that is a function of how this
evolving publishing niche is deﬁned and how its ethics are perceived.
Important to recognize is that the decision process used for inclu-
sion/exclusion of articles in any bibliographic database cannot avoid
subjective judgments. The scope of each article must be evaluated for
its relevance. With the database used in this study (Daughton and
Scuderi, 2016b “Pharmaceuticals and Personal Care Products (PPCPs):
Relevant Literature”), articles were included if they contained
environmental data or discussion of pharmaceuticals and personal
care products (PPCPs) relevant to the many facets of the PiE topic, in-
cluding origins, sources, occurrence, transport, fate, exposure, effects,
stewardship, disposal, pollution prevention, monitoring, waste and
water treatment technologies, risk assessment, risk communication,
acute poisoning, and others, as well as major articles on many aspects
that are peripherally related (e.g., important references dealing with
low-dose effects, mixture effects, and databases for medications,
physicochemical properties, and toxicology, among others). Articles
were excluded if the focus on PPCPs was judged to beminimal - requir-
ing an admittedly subjective judgment. We believe the database houses
the most extensive collection of curated articles focused solely on PiE
and which is accessible to the public.
The topic of PiE is not suited to straightforward, conventional
searches of commercial databases of the published literature because
of the lack of deﬁnitive search terms, which results in extremely large
numbers of irrelevant hits. Instead, many different types of searches
(ranging from very speciﬁc to general) must be continually performed
to locate new references to include in the database. Equally important
is the role of citation analysis (both forward and backward - using
both citing and cited articles) for locating new references. Citation
analysis is also used in this examination as a proxy for the “impact” of
speciﬁc articles. Google Scholar was used for obtaining citation counts
on individual articles (recognizing its advantages and limitations com-
pared with subscription citation services); these counts often contain
self-citations, but these become unimportant in determining which
articles are most highly cited since the overall contributions from self-
citations become diminishingly small. A discussion of citation analysis
is far beyond the scope of this examination; the reader is referred to a
recent article (Harzing, 2014 “A longitudinal study of Google Scholar
coverage between 2012 and 2013”).
Finally, note that since the primary focus of this paper is on anhistor-
ical chronology of the published literature, the decision was made to
provide more emphasis than usual to the cited papers. To each in-text
citation, which would normally use the conventional notation of
author(s) and year, the complete title has also been added. This uncon-
ventional formatting style was intended to provide the reader a more
ready understanding of what papers were being cited so that the full ci-
tations in the bibliography would not have to be frequently referred to.
It was also intended to provide added recognition to the contributions
of seminal works.
4. Findings
4.1. The trajectory of the published literature on PiE
This study made use of the articles in the PPCPs database as of April
2015. Of the total entries in the PPCPs database (22,676), 75% (16,918)
were journal articles and 4% (918)were book chapters (96were books).During the period 2000–2015, the numbers of articles published on PiE
(in journals and books) had increased yearly — from a rate of 200 per
year to a rate of 1800 per year; see Table 1, which also shows the yearly
percentage increases in numbers of publications. Relative to the prior
year, the largest yearly increases were 38% (2003), 36% (2006), and
30% (2012). The smallest increases were 3% (2010 and 2011) and 6%
(2013). About 98% of the journal articles and book chapters in the
database most directly relevant to PiE (excluding those devoted to acci-
dental poisonings and disposal) were published in the last 20 years
(after 1995, a total of 14,658); of the 14,936 spanning all years, only
278 (1.8%) were published before 1996. Compared with the respective
prior decade, in the two decades spanning 1990–1999 and 2000–
2009, the numbers of publications in journals and books have increased
by 5- and 10-fold.
The sheer size of the continually expanding published literature sur-
rounding PiE makes it readily apparent that huge challenges confront
thosewho strive for a synoptic understanding of many individual facets
of the topic. Such an understanding of the entire integratedﬁeldmay no
longer be possible. The proliferation of articles on PiE make it more
time-consuming and onerous to not only ensure that the newly
appearing articles (which takes place on a daily basis) are being com-
prehensively located, but also to discern which are the more important
— to distinguish them from those that are redundant or that represent
minor incremental additions. Synthesizing the expanding literature in
a manner that creates new understandings or knowledge may only be
possible for very specialized aspects of the topic. A fundamental
question presents itself - at which point does unfettered addition of
new articles to the published literature actually begin to impede ad-
vancements or the translation of new data into useful knowledge? The
examination presented here does not pretend to address this important
question— or the many other allied questions, such as whether contin-
ually diminishing research resources are being effectively targeted at
the most pressing needs.
4.2. Distribution of journals publishing PiE-related articles
The distribution of journals that have published PiE-related work is
highly skewed (see Supplementary Table S-1 and Supplementary
Fig. S-1). Although a total of 16,580 PiE articles were distributed
among 2295 different journals, 31% of all published articles (5186/
16580) were distributed among just eight journals: Environmental
Science & Technology (1083), Chemosphere (918), Science of the Total
Environment (744),Water Research (687), Journal of Chromatography A
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Materials (384), and Aquatic Toxicology (363). The majority of PiE arti-
cles have been published in just 50 journals, which housed 58% of all
published articles (9549 of 16,580). There were 23 journals that had
published at least 100 articles each. In contrast, 1403 different journals
had each published only a solitary article.
Notable aspects of the types of journals that have published the
world's literature on PiE include the following. Theﬁeld is predominant-
ly published in journals outside the ﬁelds of medicine and health care.
The most active journals have focused on environmental science
(especially aquatic and marine sciences), environmental toxicology,
analytical chemistry (11 journals), environmental monitoring, water
chemistry, waste treatment, water treatment, and human toxicology.
See the word cloud graphic comprising the journal-title words (exclud-
ing generic words such as journal, science, and nature) for the 65
journals that have each published at least 25 articles (see Supplementa-
ry Fig. S-2. As onemight expect, higher-impact journals published fewer
articles than many other journals; for example, Science was 27th with
87 articles, and Nature was 43rd with 59 articles.
In contrast, comparatively little has been published in journals
devoted to the ﬁelds of medicine, health care, or pharmacology. Of the
65 journals that have published more than 25 articles each, only 3 are
devoted to the ﬁelds ofmedicine or applied pharmacology: The Pharma-
ceutical Journal (33 articles), New England Journal of Medicine (32), and
The Lancet (27). These journals account for only 92 articles (0.6% of
the total number of articles in journals); many of these articles tend to
focus on childhood accidental poisonings from drugwaste, drug dispos-
al (e.g., take-back programs for unwanted drugs), and environmental
stewardship (e.g., prudent use of antibiotics and safe disposal of
unwanted drugs).
4.3. Emergence of PiE as a discrete ﬁeld of research in environmental science
Given the wide scope of environmental issues surrounding the topic
of pharmaceuticals and personal care products (PPCPs), the examina-
tion presented here will focus primarily on concerns related to the oc-
currence of APIs in the natural environment. This topic is sometimes
referred to as Pharmaceuticals in the Environment— or PiE. The exam-
ination tried to exclude from consideration articles that focused solely
on the allied topic of personal care products, which is also captured in
the PPCPs bibliographic database. These two large groups of consumer
chemicals sometimes intersect (for example, with the use of biocides
such as triclosan and triclocarban). The fact that ingredients in personal
care products can establish a presence in the environment began to
emerge in the early 1980s andmid-1990swith the identiﬁcation of syn-
thetic musks in various environmental matrices:
Eschke et al., 1994 “Untersuchungen zumVorkommen polycyclischer
Moschus-Duftstoffe in verschiedenen Umweltkompartimenten –
Nachweis und Analytik mit GC/MS in Oberﬂässern und Fischen (1.
Mitteilung) [Studies on the occurrence of polycyclic musk ﬂavors in
different environmental compartments— 1st Communication: Detection
and analysis by GC/MS in surface and sewage waters and ﬁsh]”.
Franke et al., 1995 “Organic compounds as contaminants of the Elbe
River and its tributaries. Part II: GC/MS screening for contaminants of
the Elbe water”.
Rimkus et al., 1994 “Nitro musks in human adipose-tissue and
breast-milk”.
Yamagishi et al., 1981 “Identiﬁcation of musk xylene and musk
ketone in freshwater ﬁsh collected from the Tama River, Tokyo”.
Yamagishi et al., 1983 “Synthetic musk residues in biota and water
from Tama River and Tokyo Bay (Japan)”.
This was preceded with identiﬁcation of the biocide triclosan in the
late 1970s and its environmental transformation product methyl
triclosan in 1984:
Hites and Lopez-Avila, 1979 “Identiﬁcation of organic compounds in
an industrial waste water”; Jungclaus et al., 1978 “Organic compoundsin an industrial Wastewater: a case study of their environmental
impact”; Lopez-Avila and Hites, 1980 “Organic compounds in an indus-
trial wastewater. Their transport into sediments”.
Jungclaus et al., 1978 “Organic compounds in an industrial
Wastewater: a case study of their environmental impact”.
Lopez-Avila and Hites, 1980 “Organic compounds in an industrial
wastewater. Their transport into sediments”.
Miyazaki et al., 1984 “Residues of 4-chloro-1-(2,4-dichlorophenoxy)-
2-methoxybenzene(triclosan methyl) in aquatic biota”.
These were all preceded in 1975 with study of the degradation in
sewage of the biocide trichlorocarbanilide (triclocarban):
Gledhill, 1975 “Biodegradation of 3,4,4′-trichlorocarbanilide, TCC®,
in sewage and activated sludge”.
One aspect of PiE that has caused long-time confusion is thequestion
of what is meant by a pharmaceutical, drug, or API— or even how large
the super set of APIsmight even be. This topicwas not covered in the PiE
literature until 2013:
Daughton, 2013 “Pharmaceuticals in the Environment: Sources and
Their Management”.
It still appears, however, that no authoritative estimate yet exists for
the number of medicinal, small molecular APIs in current use world-
wide; estimates for the US seem to currently range up to 2500, even
though a recent study shows that the cumulative total ever approved
in the US (through 2013) is 1453. And it is even more difﬁcult to esti-
mate the numbers of illicit and designer drugs in current use, although
the numbers continue to grow:
Kinch et al., 2014 “An overview of FDA-approved newmolecular en-
tities: 1827–2013”.
The question often arises as to when the topic of PiE ﬁrst emerged
and established itself as a discrete ﬁeld of study. There is no deﬁnitive
date that marks the emergence of the PiE ﬁeld. Rather it is a topic that
gradually coalesced from a number of isolated progenitor studies over
the course of several decades, especially in the 1970s and early 1980s.
But a concerted and rapidly expanding focus on the larger scope of the
many environmental issues that surround pharmaceuticals as environ-
mental contaminants (especially human-use drugs) began in earnest
several decades later, notably marked by the 2-year period 1998–
1999. This becomes clear when examining a select series of 93 articles
published up through 1999, which are listed in chronological order in
Supplementary Table S-2; of these articles, 37 are highlighted as
among those most highly cited from all years, with each attracting a
minimum of 200 citations (as of April 2015) according to Google
Scholar. These articleswere selected to representmanyof the numerous
facets that play interacting roles in the questions and concerns sur-
rounding the PiE topic.
The 2-year period 1998–1999 witnessed an initial explosion of 26
articles that would later become highly cited. As of April 2015, the cita-
tion counts for these 26 articles spanned the range of 203 to 3064; no-
table is that these articles continue to attract citations over 15 years
later. While this is more than twice the number of the 12 highly cited
papers over the prior 20 years (1977–1997), it is overshadowed by
the total of 348 highly cited papers during the ensuing 13-year period
2000–2012, which have attracted citation counts spanning the range
from 200 to 5424 (see Supplementary Table S-3). In total, there have
been 378 highly cited papers on PiE (each with at least 200 citations
as of April 2015). Many of these articles continue to display very long ci-
tation half-lives. The disproportionate abundance of highly cited articles
concentrated in the 2-year period 1998–1999 can be viewed as a point
in time at which PiE emerged in the literature as a discrete ﬁeld of
research.
Brieﬂy discussed below are some speciﬁc aspects to PiE that deserve
highlighting with respect to their emergence in the literature.
4.3.1. Brief history prior to 2000
Prior to 1998, comparatively few papers had directly addressed en-
vironmental issues regarding isolated pharmaceuticals. Absent was a
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pose environmental risks. The earlier publishedwork tended to focus on
very speciﬁc aspects involving agriculture and aquaculture and indirect-
ly related issues involving public health and safety (e.g., accidental poi-
sonings involving ingestion by children and wildlife of leftover or
imprudently disposed drugs).
Not yet recognized was how expansive, interconnected, and complex
the larger issue would eventually become (see Fig. 1 in. Daughton, 2008
“Pharmaceuticals as environmental pollutants: the ramiﬁcations for
human exposure”)— one thatwould eventually bring togethermany dis-
ciplines and areas of investigationwithin science, social science, engineer-
ing, and healthcare – including analytical and environmental chemistry,
environmental and human toxicology, veterinary sciences, animal hus-
bandry, aquatic and marine sciences, agricultural and plant sciences, hy-
drology, pharmacology, pharmacy science and practice, medical science
and practice, healthcare practice, nursing, social and behavioral sciences,
civil and sanitary engineering, waste treatment, water treatment, water
reuse, and risk assessment and communication– aswell as theneed to in-
form policy, legislation, and regulation.
Concerns surrounding the potential for endogenous and synthetic
steroids from human and domestic animals to enter the environment
and drinking water via sewage were being voiced in the 1950s–1970s
(and probably earlier):
Kirchner et al., 1973 “Fluoreszenzspektroskopische Bestimmung
ovulationshemmender Steroide aus Wasser und Abwassern auf der
DC-Platte [Fluorescence spectroscopic determination of anti-ovulatory
steroids inwater andwastewater on thin layer chromatography plate]”.
Norpoth et al., 1973 “Untersuchingen zur ovulationshemmender
Steroide Frage des Loslichkeit und Stabilitat in Wasser, Abwassern und
Belebtschlamm [Studies on the problem of solubility and stability of
steroid ovulation inhibitors in water, waste water, and activated
sludge]”.
Stob, 1956 “Fecal Elimination of Hormones in Sheep and Cattle
Treated with Synthetic Estrogens”.
Stumm-Zollinger and Fair, 1965 “Biodegradation of steroid
hormones”.
Tabak and Bunch, 1970 “Steroid hormones as water pollutants I.
Metabolism of natural and synthetic ovulation-inhibiting hormones by
microorganisms of activated sludge and primary settled sewage”.
von Rathner and Sonneborn, 1979 “Biologisch wirksame Östrogene
in Trink- und Abwasse [Biologically active oestrogens in portable
water and efﬂuents]”.
Wilson, 1976 “Steroids as water pollutants: a literature survey of
synthetic and natural hormonal steroids and the analytical methods
for their determination” bas cited by othersN.
Wilson, 1978 “Contraceptive steroids in water supplies”.
Stumm-Zollinger and Fair may have been the ﬁrst (in 1965) to voice
the possibility that residues of drugs or hormones “may occur in our
drinking waters,” albeit “under the most unfavorable conditions.” This
concern did not seem to be resurrected until the mid-1970s with the
work of:
Daughton, 2010b “Pharmaceutical Ingredients in Drinking Water:
Overview of Occurrence and Signiﬁcance of Human Exposure” (see ref-
erences cited therein).
Donaldson, 1977 “Trace organics in water”.
Garrison, 1977 “Analysis of organic compounds in water to support
health effects studies”.
Garrison et al., 1976 “GC/MS Analysis of Organic Compounds in
Domestic Wastewaters”.
Hignite and Azarnoff, 1977 “Drugs and drug metabolites as
environmental contaminants: Chlorophenoxyisobutyrate and salicylic
acid in sewage water efﬂuent”.
Stumm-Zollinger and Fair, 1965 “Biodegradation of steroid
hormones”.
Signiﬁcantly, the works of Garrison, Donaldson, and others in the
1970s on the characterization of low but measurable levels of knownchemicals in treated wastewaters began to lead to the eventual wide-
spread appreciation that sewage treatment may not be capable of fully
removing the most hazardous pollutants and that when removed
from the liquid phase, many of these pollutants concentrate in the
sludge; for example, see:
Petrasek et al., 1983 “Fate of Toxic Organic Compounds in
Wastewater Treatment Plants”.
The potential environmental impact of pharmaceuticals began to at-
tract some attention in the 1970s. This early literature (pre-1998)
tended to focus on three limited aspects of what would only later be-
come the ﬁeld of PiE:
(i) certain drugs used in agriculture and aquaculture (primarily an-
tibiotics, certain steroids, and agricultural antiparasitics, especial-
ly the macrocyclic lactones such as the avermectins); for
example:
Coats et al., 1976 “Model ecosystem evaluation of the environmental
impacts of the veterinary drugs phenothiazine, sulfamethazine,
clopidol, and diethylstilbestrol”.
Huber, 1971 “Antibacterial drugs as environmental contaminants”.
Nessel et al., 1989 “Environmental fate of ivermectin in a cattle
feedlot”.
Samuelsen et al., 1991 “Fate and microbiological effects of
furazolidone in a marine aquaculture sediment”.
Wall and Strong, 1987 “Environmental consequences of treating
cattle with the antiparasitic drug ivermectin”.
(ii) the recognition that antibiotics could lead to resistance in the en-
vironment — a concern that extends at least back to the 1940s;
for example:
Barber, 1947 “Staphylococcal Infection due to Penicillin-resistant
Strains”.
Demerec, 1945 “Production of Staphylococcus Strains Resistant to
Various Concentrations of Penicillin”.
Miller, 1948 “Bacterial resistance to antibiotics”.
(iii) the various aspects of stewardship and sustainable use of phar-
maceuticals — namely, the public health concerns posed by un-
used, unwanted drug waste (especially problems faced by
consumer disposal of drugs, the need for unwanted-drug take
backs, and the persistent hazard of childhood unintentional, acci-
dental ingestions from improperly stockpiled or stored medica-
tions or imprudently disposed medications in the home). These
were problems that had already begun to attract debate and dis-
cussion in the 1960s and 1970s; for example:
Bradley and Williams, 1975 “Evaluation of medicines returned in
Manchester DUMP campaign”.
Gunn and Lishman, 1967 “Letters to Editor regarding “Problem of
Unused Drugs””
Hart and Marshall, 1976 “Wastage of Pharmaceuticals”.
Overall, during the period predating the early 1990s, there were
comparatively few papers that would later prove seminal in providing
an early glimpse into the expansive scope of the PiE issue. Among
these few that have discussed the prospects of APIs occurring in sewage
or ambient waters or that established their actual presence were:
Aherne and Briggs, 1989 “The relevance of the presence of certain
synthetic steroids in the aquatic environment”.
Aherne et al., 1985 “The role of immunoassay in the analysis of
microcontaminants in water samples”.
Aherne et al., 1990 “Cytotoxic drugs and the aquatic environment:
estimation of bleomycin in river and water samples”.
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impacts of the veterinary drugs phenothiazine, sulfamethazine,
clopidol, and diethylstilbestrol”.
Garrison et al., 1976 “GC/MS Analysis of Organic Compounds in
Domestic Wastewaters”.
Gilbertson et al., 1990 “Environmental fate of ceftiofur sodium, a
cephalosporin antibiotic. Role of animal excreta in its decomposition”.
Hignite and Azarnoff, 1977 “Drugs and drug metabolites as
environmental contaminants: Chlorophenoxyisobutyrate and salicylic
acid in sewage water efﬂuent”.
Rurainski et al., 1977 “Über das Vorkommen von natürlichen und
synthetischen Oestrogenen im Trinkwasser [Concerning the
occurrence of natural and synthetic estrogens in drinking water]”.
Tabak et al., 1981 “Steroid hormones as water pollutants II. Studies
on the persistence and stability of natural urinary and synthetic
ovulation-inhibiting hormones in treated and treated wastewaters”.
Warman and Thomas, 1981 “Chlortetracycline in soil amended with
poultry manure”.
It is important to note that throughout this examination of the chro-
nology of work on PiE, there could very well be even earlier articles in
non-English journals. Much of this literature is very difﬁcult to locate
or access. Some of the articles in German or Dutch, for example, have
numerous errors in how they are cited by others; this is also true for
older reports and dissertations. For example, it is usually noted that
the ﬁrst instances of APIs being identiﬁed in water samples usually
refer back to the mid-1970s:
Garrison et al., 1976 “GC/MS Analysis of Organic Compounds in
Domestic Wastewaters”.
Hignite and Azarnoff, 1977 “Drugs and drug metabolites as
environmental contaminants: Chlorophenoxyisobutyrate and salicylic
acid in sewage water efﬂuent”.
Rurainski et al., 1977 “Über das Vorkommen von natürlichen und
synthetischen Oestrogenen im Trinkwasser [Concerning the
occurrence of natural and synthetic estrogens in drinking water]”.
But prior works on “micropollutants” had also identiﬁed chemicals
that could be associated with APIs. One example, published in 1974,
compiled data from the early 1970s where cloﬁbric acid (as mecoprop),
caffeine, some natural steroids/sterols, and other allied chemicals had
been reported; this report, however, does not explicitly mention any
connections with pharmaceuticals:
Water Research Centre, 1974 “A comprehensive list of polluting
substances which have been identiﬁed in various fresh waters, efﬂuent
discharges, aquatic animals and plants, and bottom sediments. COST pro-
ject 64b: Analysis of organic micropollutants in water”.
Some background for this 1974 Water Research Centre project can
be found here:
Penning et al., 1986 “Integration and Use of the List of Organic
Micropollutants in the Aquatic Environment in the ECDIN Data Bank”.
In 1988, theﬁrst papers to focus on environmental risk assessment for
PiE began to appear. These articles, authored by the US FDA, presaged the
eventual concerns regarding environmental impact. These included:
Matheson, 1988 “The Nuts and Bolts of Preparing an Environmental
Assessment”.
Bloom and Matheson, 1993 “Environmental assessment of
avermectins by the US Food and Drug Administration”.
Haley et al., 1993 “Requirements of the FDA for the environmental
assessment of animal health products”.
Vincent, 1993 “Environmental assessment: U.S. requirements in
new drug applications”.
As an aside, despite several decades of studies on awide spectrum of
APIs in the environment, the ﬁrst ofﬁcial methods for monitoring a se-
lect group of chemicals often targeted for PiE studies (namely various
steroids and hormones) was not published until December 2007, by
the USEPA:
USEPA, 2007 “EPA Method 1698: Steroids and hormones in water,
soil, sediment, and biosolids by HRGC/HRMS”.A concerted focus on the need for new analytical methods for APIs in
environmentalmatrices was perhaps catalyzed in large part by the very
ﬁrst large-scale monitoring study involving PiE, whichwas published in
2002 and which has become one of the most highly cited articles in
environmental science (with over 5700 citations in October 2015):
Kolpin et al., 2002 “Pharmaceuticals, hormones, and other organic
wastewater contaminants in U.S. streams, 1999–2000: a national
reconnaissance”.
In 1993 and 1994, at least two seminal papers presented another
toxicological concern – endocrine disruption – that would later become
a major research area onto itself and prove important with respect to
the potential for ecological impacts from PiE:
Colborn et al., 1993 “Developmental effects of endocrine-disrupting
chemicals in wildlife and humans”.
Purdom et al., 1994 “Estrogenic Effects of Efﬂuents from Sewage
Treatment Works”.
Note, however, that this work was preceded in 1956 by that of Stob,
who showed that synthetic hormones can be excreted by domestic an-
imals, and in 1981 by that of Tabak et al., who identiﬁed andquantiﬁed a
spectrum of steroid hormones in sewage:
Stob, 1956 “Fecal Elimination of Hormones in Sheep and Cattle
Treated with Synthetic Estrogens”.
Tabak et al., 1981 “Steroid hormones as water pollutants II. Studies
on the persistence and stability of natural urinary and synthetic
ovulation-inhibiting hormones in treated and treated wastewaters”.
4.3.2. Multiple exposure and mixture toxicity
Anothermajor area of research that has key relevance to PiE involves
multiple exposure (sometimes also referred to as co-exposure)
resulting inmixture toxicity (sometimes also referred to as combination
effects, combined effects, or joint toxicity). This is one of themajor chal-
lenges faced by toxicology today. The topic of aquatic mixture toxicity
has been an area of research extending back to the 1960s, where its ini-
tial scope of interest regarding stressors was primarily inorganic spe-
cies. A concerted focus on the toxicity of mixtures that included
organic pollutants did not begin to coalesce until the 1970s–1980s,
marked in 1987 by perhaps the ﬁrst comprehensive collection of articles
in a journal devoted to mixture effects, by Vouk et al. For examples, see
the following and the references cited therein:
EIFAC, 1987 “Working party on Water Quality Criteria for European
Freshwater Fish,Water quality criteria for European freshwaterﬁsh. Re-
vised report on combined effects on freshwater ﬁsh and other aquatic
life of mixtures of toxicants in water” (and its predecessor 1980 report).
Hermens and Leeuwangh, 1982 “Joint toxicity of mixtures of 8 and
24 chemicals to the guppy (Poecilia reticulata)”.
Konemann, 1981 “Fish toxicity tests withmixtures ofmore than two
chemicals: a proposal for a quantitative approach and experimental
results”.
Vouk et al., 1987 “Methods for assessing the effects of mixtures of
chemicals”.
Despite the decades of isolated articles, mixture toxicity did not
begin to attract concerted attention until the mid-1990s and early
2000s:
Altenburger et al., 1996 “Regulations for Combined Effects of
Pollutants: Consequences from Risk Assessment in Aquatic Toxicology”.
Carpenter et al., 2002 “Understanding the Human Health Effects of
Chemical Mixtures”.
Escher and Hermens, 2002 “Modes of Action in Ecotoxicology: Their
Role in Body Burdens, Species Sensitivity, QSARs, and Mixture Effects”.
Kortenkamp and Altenburger, 1998 “Synergisms with mixtures of
xenoestrogens: A reevaluation using the method of isoboles”.
Kortenkamp and Altenburger, 1999 “Approaches to assessing
combination effects of oestrogenic environmental pollutants”.
Mehendale, 1994 “Ampliﬁed interactive toxicity of chemicals at
nontoxic levels: mechanistic considerations and implications to public
health”.
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Chemicals on the Action of Steroidal Estrogens”.
Silva et al., 2002 “Something from “Nothing” - EightWeakEstrogenic
Chemicals Combined at Concentrations below NOECs Produce
Signiﬁcant Mixture Effects”.
Speciﬁcally with respect to PiE issues, the toxicological challenges
posed by exposure to multiple chemical stressors did not begin to re-
ceive attention until the early 2000s:
Backhaus et al., 2000a “Predictability of the toxicity of a multiple
mixture of dissimilarly acting chemicals to Vibrio ﬁscheri”.
Backhaus et al., 2000b “The single substance and mixture toxicity of
quinolones to the bioluminescent bacterium Vibrio ﬁscheri”.
Brain et al., 2004 “Microcosm evaluation of the effects of an eight
pharmaceutical mixture to the aquatic macrophytes Lemna gibba and
Myriophyllum sibiricum”.
Cleuvers, 2002 “Aquatische Ökotoxikologie ausgewählter
Arzneimittel - Algentest und akuter Daphnientest [Aquatic
ecotoxicology of selected pharmaceutical agents - Algal and acute
daphnia tests]”.
Cleuvers, 2003 “Aquatic ecotoxicity of pharmaceuticals including the
assessment of combination effects”.
Richards et al., 2004 “Effects of pharmaceutical mixtures in aquatic
microcosms”.
Much of the concern and unknowns surrounding PiE results from
the three hypotheses that: (i) chemical stressors such as APIs in the am-
bient environment often occur at individually low levels (perhaps at
levels below the accepted no-effects levels), (ii) ambient exposure for
humans andwildlife is often anongoingprocess that results from simul-
taneous or sequential exposure to multiple stressors (aggregate expo-
sure), and (iii) many APIs might impact aquatic species in subtle ways
(such as modulation of behaviors) that could be difﬁcult to discern.
The possibility that multiple, coordinated exposures might reﬂect a re-
ality of the exposure universe posed a serious obstacle to predicting tox-
icity based on individual levels of chemical stressors. These two realities
of exposure greatly impede the ability to predict and regulate the risk
incurred from ambient exposure; this is noteworthy in contrast with
the much better deﬁned conditions of occupational exposure.
One obstacle to readily locating the published literature on multiple
exposure and mixture toxicity is the lack of a single, widely used term
that reliably captures much of its scope. Required instead, are a mix of
general terms (includingmultiple exposure and mixture toxicity) com-
bined with speciﬁc terms describing the interactions between multiple
stressors, such as joint action or various modiﬁers for toxicity (or
effects), such as combined (combination), additive, interactive (such
as antagonism), enhanced (synergism), cumulative, or ampliﬁed. The
most commonly used general terms, however, might be multiple
exposure andmixture toxicity (combined effects), whose usage extends
back into the 1980s.
4.3.3. Inhibition of multidrug resistance
A speciﬁc type of mixture effect relates to the inhibition of the
endogenous protective mechanism that promotes the cellular efﬂux of
toxicants—multidrug resistance (MDR). The ability of certain APIs to in-
hibit MDR can enhance the aquatic toxicity of xenobiotics (including
other APIs). The role of MDR and its inhibition in aquatic exposures
was pioneered and reviewed by Kurelec in 1992, and was soon speciﬁ-
cally termed multixenobiotic resistance (MXR) with respect to aquatic
organisms by Toomey and Epel (1993):
Kurelec, 1992 “Themultixenobiotic resistancemechanism in aquatic
organisms”.
Toomey and Epel, 1993 “Multixenobiotic Resistance inUrechis caupo
Embryos: Protection from Environmental Toxins”.
This initial work was further elaborated upon by research from
Kurelec's and Epel's groups in the 1990s:
Kurelec, 1995 “Inhibition of multixenobiotic resistance mechanism
in aquatic organisms: ecotoxic consequences”.Kurelec, 1997 “A new type of hazardous chemical: the
chemosensitizers of multixenobiotic resistance”.
Müller et al., 1996 “Themultixenobiotic resistancemechanism in the
marine sponge Suberites domuncula: its potential applicability for the
evaluation of environmental pollution by toxic compounds”.
Smital and Kurelec, 1997 “Inhibitors of the multixenobiotic
resistance mechanism in natural waters: in vivo demonstration of
their effects”.
Smital and Kurelec, 1998 “The chemosensitizers of multixenobiotic
resistance mechanism in aquatic invertebrates: a new class of
pollutants”.
Reviews of the importance ofMXR for aquatic toxicitywereﬁrst pro-
vided by Epel in 1998 and by Bard in 2000, followed by continued stud-
ies by Epel and Smital:
Bard, 2000 “Multixenobiotic resistance as a cellular defense
mechanism in aquatic organisms”.
Epel, 1998 “Use of multidrug transporters as ﬁrst lines of defense
against toxins in aquatic organisms”.
Epel and Smital, 2001 “Multidrug — multixenobiotic transporters
and their signiﬁcance with respect to environmental levels of
pharmaceuticals and personal care products”.
Work by others followed in 2008:
Caminada et al., 2008 “Human pharmaceuticals modulate P-gp1
(ABCB1) transport activity in the ﬁsh cell line PLHC-1”.
Luckenbach and Epel, 2008 “ABCB- and ABCC-type transporters con-
fer multixenobiotic resistance and form an environment-tissue barrier
in bivalve gills”.4.3.4. Subtle effects
Because the mechanisms of biological action (or adverse outcome
pathways) for APIs can be distinctly different from those of convention-
al (legacy) pollutants, the potential for subtle effects
(e.g., neurobehavioral; efﬂux pump inhibition)was ﬁrst raised as a pos-
sibility in 1999:
Daughton and Ternes, 1999 “Pharmaceuticals and personal care
products in the environment: Agents of subtle change?”
This hypothesis, which initially focused on selective serotonin reup-
take inhibitors (SSRIs) and efﬂux pump inhibitors (MXR), was largely
catalyzed by preexisting aquaculture research on the induction of
spawning by the use of serotonin — in particular the work of Fong in
1998:
Fong, 1998 “Zebra mussel spawning is induced in low
concentrations of putative serotonin reuptake inhibitors”.
Interest and research on the potential for subtle effects – particularly
from low-level exposure to SSRIs – began in the early 2000s, with work
from Brooks, Fong, and others:
Brooks et al., 2003a “Aquatic ecotoxicology of ﬂuoxetine”.
Brooks et al., 2003b “Waterborne and sediment toxicity of ﬂuoxetine
to select organisms”.
Fong, 2001 “Antidepressants in aquatic organisms: a wide range”.
Research continues to expand the focus on subtle effects with
respect to PiE:
Jeong et al., 2015 “Multi-generational effects of propranolol on
Daphnia magna at different environmental concentrations”.
Nunes, 2015 “How to Answer the Question— Are Drugs Real Threats
to Biological Systems or Overrated Innocuous Chemicals?”
It should be noted, however, that the shift of focus from conventional
aquatic toxicity end points (e.g., lethality) to more subtle and difﬁcult-
to-observe end points really began in the mid-1990s with the observa-
tion of subtle changes in ﬁsh intersexuality (and the emergence of the
intersecting topic of endocrine disruption and EDCs):
Bortone and Davis, 1994 “Fish intersexuality as indicator of
environmental stress”.
Crisp et al., 1998 “Environmental endocrine disruption: an effects
assessment and analysis”.
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Kingdom inland waters”.
Isomaa and Lilius, 1995 “The urgent need for in vitro tests in
ecotoxicology”.
Sumpter and Jobling, 1995 “Vitellogenesis as a Biomarker for
Estrogenic Contamination of the Aquatic Environment”.4.4. Gauging the emergence of PiE in the published literature
There are three major approaches for examining the chronology of
PiE in its emergence as an issue attracting growing attention or concern.
One is by chronicling the ﬁrst scientiﬁc conferences devoted to PiE and
the subsequent attention by news media. A second is by documenting
the introduction to the published literature of new jargon and acronyms
that are speciﬁc to – or closely allied with – the ﬁeld. These can be
viewed as landmarks ormilestones for a ﬁeld's development. The emer-
gence of terms and acronyms is sometimes driven by the need to deﬁne
new insights or perspectives deemed important or that require new
ways to communicate. And the thirdmajor approach is by bibliographic
citation analysis, which can reveal which published works are the most
highly cited - possibly reﬂecting their value to the citing authors and
their impact on the ﬁeld or the general science community. Examples
from each of these approaches are presented below.4.4.1. First published articles on PiE
The ﬁrst studies speciﬁcally focused on pharmaceuticals as environ-
mental contaminants began to appear from 1976 to 1985, but there
were comparatively few. Some of the more signiﬁcant include:
Caballa et al., 1979 “A Terrestrial-Aquatic Model Ecosystem for Eval-
uating the Environmental Fate of Drugs and Related Residues in Animal
Excreta”.
Coats et al., 1976 “Model ecosystem evaluation of the environmental
impacts of the veterinary drugs phenothiazine, sulfamethazine,
clopidol, and diethylstilbestrol”.
Richardson andBowron, 1985 “The fate of pharmaceutical chemicals
in the aquatic environment”.
Rurainski et al., 1977 “Über das Vorkommen von natürlichen und
synthetischen Oestrogenen im Trinkwasser [Concerning the
occurrence of natural and synthetic estrogens in drinking water]”.
Tabak et al., 1981 “Steroid hormones as water pollutants II. Studies
on the persistence and stability of natural urinary and synthetic
ovulation-inhibiting hormones in treated and treated wastewaters”.
Waggott, 1981 “Trace organic substances in the River Lee”.
Wilson, 1976 “Steroids as water pollutants: a literature survey of
synthetic and natural hormonal steroids and the analytical methods
for their determination” bas cited by othersN.
Wilson, 1978 “Contraceptive steroids in water supplies”.
For some context and perspective, these studieswere being initiated
at a time (the 1970s) when it was believed by some that what would
years later become the PiE issue posed little concern, as reﬂected in
the following excerpt (from: Peck, 1977 “The Environmental Impact of
Drugs”):
“With fewexceptions… drugs are not studied for their effects on the
environment, i.e., birds, ﬁshes, plants, since they are not intended to be
used in such a way that there would be a signiﬁcant impact on the
environment.”
The following, in particular, probably reﬂectsmuch of the thinking at
that time:
“The impact of drugs on the environment can be considered to be
rather minimal because of the controlled manner in which most drugs
are used…. As a rule the beneﬁt/risk evaluation of drugswould indicate
that even though there might be some impact on the environment, this
should be small, and it is probable that the beneﬁts would outweigh the
risk.”4.4.2. Journal special issues devoted to PiE
The advent of a new concern is often marked by journals devoting a
“special issue” to the topic. Four of the ﬁrst journal special issues devoted
to articles on PiEwere published in 1999–2002: (i) a 1999 collection of 15
articles in Science of the Total Environment (TOC: http://www.
sciencedirect.com/science/journal/00489697/225/1-2), (ii) a 2000 collec-
tion comprising 8 articles in Chemosphere (TOC: http://www.
sciencedirect.com/science/journal/00456535/40/7), (iii) a 2001 collec-
tion, including 6 articles, in Journal of Contemporary Water Research and
Education (TOC: http://opensiuc.lib.siu.edu/jcwre/vol120/iss1/), and (iv)
a 2002 collection of upwards of 14 articles in Toxicology Letters (TOC:
http://www.sciencedirect.com/science/journal/03784274/131/1-2):
Ternes, 1999 “Drugs and Hormones as Pollutants of the Aquatic
Environment: Determination and Ecotoxicological Impacts”.
Jørgensen and Halling-Sørensen, 2000 “Drugs in the environment”.
Masters, 2001 “Pharmaceuticals and Endocrine Disruptors in Rivers
and on Tap”.
Dietrich et al., 2002a “Hot Spot Pollutants: Pharmaceuticals in the
Environment”.
An earlier special issue, in 1993, comprised roughly 30 papers and
was devoted entirely to the topic of avermectins and the environment.
It was published in Veterinary Parasitology (TOC: http://www.
sciencedirect.com/science/journal/03044017/48; this effort was cata-
lyzed by the earlier, highly cited work of Wall and Strong in 1987:
Herd and Wardhaugh, 1993 “Environmental Impact of Avermectin
Usage in Livestock”.
Wall and Strong, 1987 “Environmental consequences of treating
cattle with the antiparasitic drug ivermectin”.
4.4.3. Science conferences devoted to PiE
The advent of a new concern is also often reﬂected by science confer-
ences that are dedicated in part or entirely to the topic. The ﬁrst confer-
ences and symposia devoted to PiE (in North America and Europe)were
held within a 3-month period in 2000, marking a point at which wide-
spread interest had crystallizedwithin the environmental science arena.
These initial conferences triggered numerous follow-on regional and
local conferences on PiE. They were sponsored by the ACS, AWWARF,
SETAC, and NGWA:
ACS, 2000 (27March) “Special Symposiumon ‘Pharmaceuticals in the
Environment’” (ﬁrst-ever all-day symposium in North America on PiE).
AwwaRF, 2000 “Endocrine Disruptors & Pharmaceutically Active
Chemicals in Drinking Water Workshop”.
SETAC, 2000 (21–25May) “Veterinary and humanpharmaceuticals -
fate and effects”.
NGWA, 2000 (7–8 June) “Emerging Issues Conference –
pharmaceuticals – endocrine disrupting chemicals - pesticides -
arsenic and radon”.
The ﬁrst meeting on PiE that was organized by the USEPA was held
in 2005:
USEPA, 2005 (23–25 August) “Session on Environmental
Stewardship for Pharmaceuticals in the Environment”.
Worth noting is that these conferences that focused on PiEwere pre-
ceded decades earlier with several whose focus was on the predecessor
issue of trace levels in waters of organic pollutants in general:
Keith, 1976b “Recent advances in the identiﬁcation and analysis of
organic pollutants in water”.
Bjørseth and Angeletti, 1982 “Analysis of Organic Micropollutants in
Water”.
Angeletti and Bjørseth, 1984 “Analysis of Organic Micropollutants in
Water: Proceedings of the Third European Symposium held in Oslo,
Norway, September 19–21, 1983”.
NRC, 1999 “Identifying Future Drinking Water Contaminants”.
4.4.4. News media coverage of PiE
Stories in the news media are somewhat more difﬁcult to locate, as
the archiving and search utilities for news articles are not as
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may well be news articles (especially in the non-English media) that
predate those mentioned here. News articles, whether published in
the lay press or in scientiﬁc journals, capture current activities in science
(primarily conference presentations, press releases from research
institutions, and select, newly published journal articles) when they
are perceived as having the potential to capture public interest. A few
news articles related to PiE began to appear in the late 1980s. But it
was not until 10 years later – in the late 1990s – that an initial cascade
of news articles began to appear.
One of theﬁrst news reports (in 1988) brieﬂy covered someof the key
concerns thatwould later fallwithin the future PiE issue.While disposal of
unwanted medications to sewers had already been practiced for decades
as a means of preventing accidental poisonings in children, this news re-
port noted that the practice could lead to other problems, primarily
(i) disposal of antibiotics to sewers could disrupt the action of microor-
ganisms needed for efﬁcient functioning of sewage treatment, and (ii)
disposal to sewers ofmedications in general could lead to residues not re-
moved during sewage treatment making their way into the environment
and drinking water (Anon., 1988 “Disposal of pharmaceutical waste”).
There was also considerable discussion surrounding the reasons that so
many drugs would go unused and later require disposal (e.g., Wilson,
1991 “Forum: Too much of a good thing — John Wilson wonders how
many people even start taking the tablets”) and that charitable donations
of medications could cause a host of other, unanticipated problems
(e.g., Purvis, 1996 “The goodwill pill mess”).
Perhaps it was the early media attention related to endocrine disrup-
tion (“hormone mimics”) – especially the “environmental estrogens and
androgens” – that drove the subsequent attention for PiE that soon
followed. The following chronology of news articles serve as early exam-
ples (1998–2000) from the ﬂurry of initial media interest in the PiE issue:
Montague, 1998 “Drugs in the water”.
Raloff, 1998 “Drugged waters— Does it matter that pharmaceuticals
are turning up in water supplies”.
Reuters, 1998 (8 October) “Researchers ﬁnd estrogen-like chemicals
in toiletries”.
Raloff, 1999 “Medicinal waters: where ibuprofen goes— the ﬁnding
of cloﬁbric acid and diclofenac in the water of Swiss lakes, leads to the
question of why ibuprofen was not being found”.
Bowman, 2000 “Medicines, Chemicals Taint Water: Contaminants
Pass Through Sewage Plants”.
Carr, 2000 “Flush with drugs: Waterways examined for potential
risks posed by medicines released down drains”.
Chui, 2000 “Tainted waters: Trace amounts of medicine, lotions and
household products are showing up in waterways”.
Dobson, 2000 “Anti-depressants get into water system”.
Dunne, 2000 “Pharmaceutical pollution: Traces of medicines found
in N.O.-area water”.
Hall, 2000 “Makeup, medication may pollute waterways”.
Manning, 2000 “Traces of drugs found in LVWash”.
Mansur and Martellaro, 2000 “Rivers face new threat: Medicines”.
Montague, 2000 “Pay dirt from the human genome”.
Potera, 2000 “Drugged drinking water”.
Raloff, 2000a “Excreted drugs: Something looks ﬁshy”.
Raloff, 2000b “More waters test positive for drugs”.
Woods, 2000 “Researchers warn of drug pollution: Drug, chemical
residue found in waterways”.
Zuer, 2000 “Drugs down the drain: Surprisingly little research exists
on the potential environmental effects of pharmaceuticals and personal
care products”.
A major contributor of these early articles was Janet Raloff, who
wrote perhaps the ﬁrst major news expose on PiE (“Drugged waters”),
published on 21 March 1998. An article by Peter Montague, which
followed in September 1998, also generated considerable attention.
But the press article that eventually attracted the most attention was
not published until 8 years later - by the Associated Press:Donnet al., 2008 “Pharmaceuticals found in drinkingwater, affecting
wildlife and maybe humans”.
The Associated Press article was widely distributed and fostered a
series of follow-up articles on PiE by the Associated Press: see:
Associated Press, 2008 “An AP Investigation: Pharmaceuticals Found
in Drinking Water”.
Some of these news stories paralleled the early scientiﬁc confer-
ences. PiE became a topic for cover stories (in 2008) in Chemical & Engi-
neering News, including:
Halford, 2008a “Don't Flush: What to Do with Your Unused
Pharmaceuticals”.
Halford, 2008b “Side Effects: Pharmaceuticals have been ﬁnding
their way into our environment for a long time, but just what are they
doing there?”
Rouhi, 2008 “Drug Pollution”.4.4.5. The ﬁrst web site devoted to PiE (PPCPs)
Largely because of the news attention that began in 1998, the ﬁrst
web site devoted to the larger topic of PPCPs was created in April
2000 by Daughton at the US EPA. Its now-defunct URL was: http://
www.epa.gov/nerlesd1/chemistry/pharma/index.htm); 7 years later
(on 18 July 2007), this web site was subsumed by the US EPA/ORD's
PPCPs web site: http://www.epa.gov/ppcp. The ORD site was then ter-
minated (8 years later, on 1 October 2015), with plans to initiate a
new US EPA PPCPs web site in 2016.4.4.6. First books devoted to PiE
Books, review articles, and university dissertations are excellent in-
dicators of when a ﬁeld of investigation has reached a critical level of in-
terest or sustained level of research activity. The ﬁrst books to focus on
aspects of PiE began to appear in 2001, although theywere preceded by
somewhose focus was on what would later be called endocrine disrup-
tion and which would have relevance to PiE (e.g., Committee on
Hormonally Active Agents in the Environment et al., 1999
“Hormonally Active Agents in the Environment”). The major initial
books devoted to PiE appeared from 2001 to 2006 and included:
Daughton and Jones-Lepp, 2001 “Pharmaceuticals and Personal Care
Products in the Environment: Scientiﬁc and Regulatory Issues”.
Kümmerer, 2001b “Pharmaceuticals in the environment — Sources,
fate, effects and risks”.
Weyer and Riley, 2001 “Endocrine disruptors and pharmaceuticals
in drinking water”.
Williams, 2005 “Human pharmaceuticals: Assessing the impacts on
aquatic ecosystems”.
Bengtsson et al., 2006 “Environment and pharmaceuticals”.
Kümmerer's 2001b book was followed by a 2nd edition in 2004 and
a 3rd edition in 2008:
Kümmerer, 2004a “Pharmaceuticals in the environment — Sources,
fate, effects, and risks”.
Kümmerer, 2008 “Pharmaceuticals in the environment — Sources,
fate, effects, and risks”.4.4.7. First comprehensive review articles devoted to PiE
The earliest review articles relevant to PiE focused on antibiotics in
the environment, beginning in the 1970s; examples include:
Huber, 1971 “Antibacterial drugs as environmental contaminants”.
Addison, 1984 “Antibiotics in sediments and run-off waters from
feedlots”.
The ﬁrst comprehensive reviews dedicated to the larger issue of PiE
did not appear until over a decade later (in 1985) and then again not
until 13 years later, during 1998–2000:
Ayscough et al., 2000 “Review of Human Pharmaceuticals in the
Environment”.
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oestrogens”.
Christensen, 1998 “Pharmaceuticals in the Environment—A Human
Risk?”
Daughton and Ternes, 1999 “Pharmaceuticals and personal care
products in the environment: Agents of subtle change?”
Halling-Sorensen et al., 1998 “Occurrence, fate and effects of phar-
maceutical substances in the environment— A review”.
Jørgensen and Halling-Sørensen, 2000 “Drugs in the environment”.
Richardson andBowron, 1985 “The fate of pharmaceutical chemicals
in the aquatic environment”.
Stahlschmidt-Allner et al., 1997 “Endocrine disrupters in the aquatic
environment”.
Velagaleti, 1997 “Behavior of pharmaceutical drugs (human and
animal health) in the environment”.
Wilken et al., 2000 “Pharmaceuticals in sewage, surface and drinking
water in Germany”.
Five of theﬁrst reviews thatwere published in journals have each re-
ceived citations from otherworks ranging from 209 to 3064. In contrast,
the ﬁrst two reviews published in a book and the two as reports had
fewer than 11 citations each. This probably just reﬂects the greater
ease of access to journal articles.
4.4.8. First academic dissertations devoted to PiE
The topic of PiE did not begin to serve as a concerted focus for Doc-
toral andMasters dissertations until 1996. Four of the earliest examples
were from 1996 to 2000:
Hagan, 1996 “An examination of acute environmental toxicity of
pharmaceutical compounds using quantitative structure-activity rela-
tionships (Daphnia magna)”.
Hartmann, 1998 “Drug load of hospital wastewater and its
ecotoxicological relevance”.
Holten Lützhöft, 2000 “Environmental risk assessment of
antimicrobials”.
Jiménez-González, 2000 “Life Cycle Assessment in Pharmaceutical
Applications”.
Note, however, that these were preceded two decades earlier by at
least one other:
Wilson, 1978 “Contraceptive steroids in water supplies”.
4.4.9. Illicit drugs
Although the focus of PiE has tended to be on prescription (legend)
and over-the-counter pharmaceuticals, the parallel galaxy of so-called
illicit drugs shares many of the same concerns. The two directly overlap
where legal controlled substances are illegally diverted for recreational
use and abuse. Drugs designated as controlled substances with no rec-
ognized medical use (Schedule I in the U.S.) and designer drugs
(e.g., illegal analogs of registered pharmaceuticals) also pose the same
concerns as do licit pharmaceuticals with regard to ecological risk. So
the study of PiE actually covers the full gamut of substances that are
used as drugs in any capacity.
The extent towhich the universe of licit and illicit drugs can become
convoluted is illustrated by the practice of adulteration. Adulteration is
used in the preparation of counterfeit drugs, which can contain legal
drugs but with illegal substances added as adulterants. It is also
practiced in the preparation of illicit drugs, which are sometimes
adulterated with otherwise legal drugs - an example being the addition
of large quantities of the cytotoxic veterinary anthelmintic levamisole to
cocaine (Daughton, 2011 “Illicit Drugs: Contaminants in the
Environment and Utility in Forensic Epidemiology”). Both licit and illicit
drugs can therefore serve as sources for each other in the environment.
Interest in illicit drugs in the environment was catalyzed by a con-
cept proposed by Daughton in 2001 (Daughton, 2001 “Illicit drugs in
municipal sewage: Proposed new non-intrusive tool to heighten public
awareness of societal use of illicit/abused drugs and their potential for
ecological consequence”), where residues of illicit drugs in sewagecould be used to back-calculate community-wide consumption, and
by the work of Zuccato et al. 4 years later – the ﬁrst to reduce the con-
cept to practice (Zuccato et al., 2005 “Cocaine in surface waters: A
new evidence-based tool tomonitor community drug abuse”); it should
be noted, however, that the concept of monitoring sewage for con-
trolled substances was ﬁrst mentioned 9 years prior to Daughton's con-
cept in a patent application (McClellan and Castorani, 1990 “Continuous
(ﬂexible) sewage monitoringmachine for sampling building efﬂuent to
measure for certain controlled substances”) on the continuousmonitor-
ing of wastewater from buildings for the presence of controlled
substances (as a lower-cost streamlined approach for collective urinal-
ysis). No further discussion will be provided here regarding the history
behind the published literature regarding the environmental concerns
regarding illicit drugs. This history has been captured in the following
review (see Table 1, therein):
Daughton, 2011 “Illicit Drugs: Contaminants in the Environment and
Utility in Forensic Epidemiology”.
4.4.10. Pollution prevention, stewardship, pharmEcovigilance, disposal,
collection take-backs, EPR
The many problems posed by the fact that signiﬁcant portions of
many medications go unused collectively constitute an integral aspect
of the overall PiE issue. Unused, leftover, unwanted medications have
played a number of roles in the evolution of the PiE published literature.
Although there are few unique words to this facet of PiE, its relevant
published literature can often be located with various combinations of
the search words: disposal (or disposed) with drug (or pharmaceutical
or medication); searches can be further narrowed with special terms
such as pollution prevention, stewardship, pharmEcovigilance (or
ecopharmacovigilance), and take-backs.
In the 1940s and earlier, the fact that small doses of certain medica-
tions can be lethal to children raised awareness of the acute hazards
posed by medications that have been improperly stored or disposed:
Shirreff and Pearlman, 1940 “Oil of wintergreen poisoning: (Report
of Two Additional Fatal Cases)”.
Troll and Menten, 1945 “Salicylate poisoning: report of four cases”.
This concern later expanded in the1990s once itwas recognized that
many commonmedications can be fatal for children in very small doses
— sometimes a single adult dose – posingmajor concerns regarding the
storage, handling, and disposal of these medications:
Koren, 1993 “Medications which can Kill a Toddler with One Tablet
or Teaspoonful”.
Liebelt and Shannon, 1993 “Small doses, big problems: a selected
review of highly toxic common medications”.
Fatal accidental ingestions were partly responsible for a growing
focus in the 1960s on the practices of stockpiling and disposal of un-
wanted, leftover medications in the home — a concern that continues
to grow and which has been greatly exacerbated today by the newer
problems of drug diversion, misuse, and abuse — for example:
Ferguson, 2014 “Keeping Families Safe Around Medicine”.
Lewis et al., 2014 “What Do Patients Do with Unused Opioid
Medications?”
Lovegrove et al., 2014 “Emergency Hospitalizations for
Unsupervised Prescription Medication Ingestions by Young Children”.
The need for prudent collection and disposal of leftover, unwanted
drugs was recognized as a means for reducing childhood poisonings
and fatalities as early as the 1960s:
Gunn and Lishman, 1967 “Letters to Editor regarding “Problem of
Unused Drugs””
Nicholson, 1967 “Collection of unwanted drugs from private
homes”.
A decade later, the recognition that medications often went unused
and served as a major cause of childhood poisonings drove efforts to
improve prescribing practices, reduce drug leftovers (which are often
subsequently disposed to sewers), and reduce the storage of unwanted
drugs in the home. These led to various organized disposal programs,
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(e.g., Glassmeyer et al., 2009 “Disposal practices for unwanted
residential medications in the United States”):
Harris et al., 1979 “Returned-medicines campaign in Birmingham”.
Leach andWhite, 1978 “Use and wastage of prescribedmedicines in
the home”.
Sixsmith and Smail, 1978 “Evaluation of medicines returned in
Glasgow DUMP campaign”.
Taylor, 1978 “Towards better prescribing”.
Formal consumer take-back programs date back to 1975 with the
Manchester unwanted drug collection campaign (also known as a
“take-back”) dubbed “DUMP”: Disposal of Unused Medicines and Pills.
DUMP later became a generic acronymused in other take-back programs.
Bradley and Williams, 1975 “Evaluation of medicines returned in
Manchester DUMP campaign”.
Implementation of consumer take-backs in the U.S. (primarily im-
plemented at local levels) did not take hold until the mid-2000s, de-
layed partly because of complexities associated with the handling of
controlled substances under the Controlled Substances Act (DEA, 2014
“Disposal of Controlled Substances 21 CFR Parts 1300, 1301, 1304,
1305, 1307, and 1317”). These obstacles were largely overcome once
the U.S. Drug Enforcement Administration (DEA) published its ﬁnal
rule implementing the Secure and Responsible Drug Disposal Act of
2010 (Senate and House of Representatives of the United States of
America in Congress, 2010 “Secure and Responsible Drug Disposal Act
of 2010”). Consumer take-back events received greater recognition
from the public once the DEA's National Take-Back Initiative was
established in 2010:
DEA, 2010 “Press release: DEA Heads First-ever Nationwide Pre-
scription Drug Take-back Day”.
The importance of take-backs (for preventing drug diversion and ac-
cidental poisonings) received its greatest endorsement when take-
backs were highlighted in a weekly public address by the President of
the United States on 26 September 2015:
Ofﬁce of the Press Secretary, 2015 “Weekly Address: Dispose of Your
Expired and Unwanted Prescription Drugs”.
It is useful to point out that the frequent U.S. news coverage
beginning in the early 2000s regarding the need for “prudent” disposal
of unwanted drugs was driven largely by the still unsubstantiated pre-
sumption that reducing the disposal of unwanted drugs to sewers
could signiﬁcantly reduce the levels of corresponding APIs in the envi-
ronment. Such a connection, however, has never been documented.
Rather, the need for prudent disposal is primarily driven by the imper-
ative to reduce accidental poisonings (especially those leading to seri-
ous morbidity or fatalities):
Daughton, 2010a “Drugs and the Environment: Stewardship &
Sustainability”.
Daughton and Ruhoy, 2008 “The afterlife of drugs and the role of
pharmEcovigilance”.
Daughton and Ruhoy, 2009 “Environmental footprint of
pharmaceuticals: The signiﬁcance of factors beyond direct excretion to
sewers”.
Worthmentioning is a speciﬁc type of drug take-back that is a man-
datory program designed around extended producer responsibility
(EPR). EPR places responsibility for product life-cycle management on
the manufacturer, in contrast to consumer take-backs, which are
voluntary and funded by the public. The adoption of EPR in the U.S. for
the collection of unused drugs was ﬁrst suggested in 2001:
Daughton, 2001 “Pharmaceuticals and personal care products in the
environment: Overarching issues and overview”.
In the years following, a number of states and local governments
proposed EPR for unused drug take-backs. But it was not until July
2012 that the ﬁrst EPR legislation in the U.S. for unwanted drugs was
enacted — by Alameda County, California:
Alameda County, 2012 “NewCounty Policy Requires DrugMakers to
Pick Up Disposal Costs”.The adoption of EPRmodels in the U.S. for unwanted drugs has been
a rather contentious issue - and one with a complex history:
Karst, 2015 “U.S. Supreme Court is Asked to Review First-in-the-Na-
tion Safe Drug Disposal Ordinance”.
Whalen, 2015 “U.S. Supreme Court Decides Not to Hear
Pharmaceutical Industry Case Against Drug Disposal Law”.
Wick, 2014 “Comment: Mandatory Drug Take-Back Programs: Will
They Survive the Dormant Commerce Clause Challenge?”
Formal consumer take-back collection programs were becoming
established in the 1970s, as well as studies examining economic costs
to hospitals of leftover medications and studies aimed at consumer
education to improve household safety:
Bradley and Williams, 1975 “Evaluation of medicines returned in
Manchester DUMP campaign”.
Dershewitz and Williamson, 1977 “Prevention of childhood
household injuries: a controlled clinical trial”.
Hart and Marshall, 1976 “Wastage of Pharmaceuticals”.
Leach andWhite, 1978 “Use and wastage of prescribedmedicines in
the home”.
Numerous studies have built on the areas summarized above; these
areas remain active asﬁelds of investigation, primarily because acciden-
tal childhood poisonings and drug diversion and abuse have not de-
clined as public health issues. This is reﬂected by the growing size of
the literature associated with the many facets of leftover, unwanted
drugs. This literature currently comprises thousands of articles and
has been compiled here:
Daughton and Scuderi, 2016a “Drug Disposal and Environmental
Stewardship: Relevant Literature”.
These studies served as the prelude to themuch later recognition, in
the mid-1990s, that the practice of medicine plays a major role in the
entry of APIs to the immediate and natural environments and that
healthcare providers and drug manufacturers should therefore play
major roles in ways to reduce or minimize the problem:
Eckerman and Martineus, 1997 “Medicines and the environment —
what do we know today?”
Menicucci and Coon, 1993–1994 “Environmental Regulation of
Health Care Facilities: A Prescription for Compliance”.
USEPA, 1994 “Guides to Pollution Prevention. Selected Hospital
Waste Streams”.
Concerns regarding the potential for environmental effects may
have been expressed several years earlier (in 1991) by Vaarkamp with
respect to the practice of veterinary medicine:
Vaarkamp, 1991 “De veterinaire praktijk en het milieu: wat te doen
en wat te laten [Veterinary practice and the environment: what to do
and what to omit]”.
Note, however, that these articles were preceded by interest in the
engineered treatment of waste streams from the manufacture of phar-
maceuticals, which emerged in the 1950s and 1960s; see the many ref-
erences cited in the 1975 U.S. EPA report:
Struzeski, 1975 “Waste treatment and disposal methods for the
pharmaceutical industry”.
That consumer drug waste disposal has environmental
connections was ﬁrst formally recognized in Canada in 1995 with the
rebranding of an existing drug collection program under the EnviRx
name:
Cameron, 1996 “Study by Alberta pharmacists indicates drug
wastage a “mammoth” problem”.
But it was not until 1999–2002, that connections between the
disposal of unwanted, leftover drugs and the environment were noted
and suggestions to adopt preventative measures made:
Campbell, 2002 “Pharmaceuticals in the environment: Regulatory
and nonregulatory approaches”.
Daughton, 2002 “Environmental stewardship and drugs as
pollutants”.
Daughton and Ternes, 1999 “Pharmaceuticals and personal care
products in the environment: Agents of subtle change?”
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pharmaceuticals in and after emergencies”.
One of the ﬁrst dedicated discussions in a pharmacy journal of the
need to understand the connection between drug waste and the
environment appeared in 2002:
Smith, 2002 “Managing Pharmaceutical Waste: What Pharmacists
Should Know”.
The concept of the “Green Pharmacy”was introduced in 2003 as the
ﬁrst comprehensive approach combining environmental stewardship,
pollution prevention, and waste reduction for reducing the entry of
APIs to the environment:
Daughton, 2003a “Cradle-to-cradle stewardship of drugs for
minimizing their environmental disposition while promoting human
health. I. Rationale for and avenues toward a green pharmacy”.
Daughton, 2003b “Cradle-to-cradle stewardship of drugs for
minimizing their environmental disposition while promoting human
health. II. Drug disposal, waste reduction, and future directions”.
This work has served as the foundation for a number of subsequent
works on environmental stewardship targeted at PiE:
Daughton, 2014a “Drug Disposal & Stewardship: Ramiﬁcations for
the Environment and Human Health”.
The concept of pharmEcovigilance (as an integrative term for
aligning the existing, conventional process of pharmacovigilance for
tracking and ensuring the safety of medications with the parallel need
for environmental protection) was introduced in 2008. One intention
of pharmEcovigilance was to link protection of the environment with
improved quality and reduced cost of medical care:
Daughton and Ruhoy, 2008 “The afterlife of drugs and the role of
pharmEcovigilance”.
Other terms also emerged in the 2006–2008 time frame, including:
ecopharmacovigilance, ecopharmaco-stewardship, and pharmaco-
environmentology:
Keck, 2006 “Teaching environmental toxicology for veterinary
students and veterinarians: some new trends”.
Rahman et al., 2007 “Pharmacoenvironmentology— a component of
pharmacovigilance”.
Kampa, 2008 “Proceedings of the expert workshop on the design of
instruments to limit pollution from PPs”.
Debate exists, however, as to whether these multiple terms are
needed:
Rahman, 2015 “Do we really need multiple terms for a single
concept in the ﬁeld of Environmental Pharmacovigilance?”
Another major work to focus on the sustainable use of medications
was published in 2009:
Bengtsson et al., 2009 “A Healthy Future - Pharmaceuticals in a
Sustainable Society”.
4.4.11. Risk and environmental assessment
The ﬁrst articles to focus on the process of assessing environmental
risk of pharmaceuticals predated the ﬁeld of PiE. They were published
by the US FDA, ﬁrst in 1988 and later in 1993 [some were in the form
of Environmental Impact Statements (EISs) and others in the form of
Findings of No Signiﬁcant Impact (FONSIs)], and by others beginning
in 1994:
Matheson, 1988 “The Nuts and Bolts of Preparing an Environmental
Assessment”.
Bloom and Matheson, 1993 “Environmental assessment of
avermectins by the US Food and Drug Administration”.
Haley et al., 1993 “Requirements of the FDA for the environmental
assessment of animal health products”.
Vincent, 1993 “Environmental assessment: U.S. requirements in
new drug applications”.
Sager and Williams, 1994 “Environmental Assessment and Finding
of No Signiﬁcant Impact for TOPAMAX® (Topiramate)”.
These articles were largely preceded by a number of unconnected
articles (1970–1990) that began to hypothesize or examine thepotential for various environmental impacts from speciﬁc APIs, years
before any sense of the larger PiE issue had begun to coalesce. Notewor-
thy is the seminal review in 1985 by Richardson and Bowron:
Aherne and Briggs, 1989 “The relevance of the presence of certain
synthetic steroids in the aquatic environment”.
Aherne et al., 1990 “Cytotoxic drugs and the aquatic environment:
estimation of bleomycin in river and water samples”.
Hignite and Azarnoff, 1977 “Drugs and drug metabolites as
environmental contaminants: Chlorophenoxyisobutyrate and salicylic
acid in sewage water efﬂuent”.
Richardson and Bowron, 1985 “The fate of pharmaceutical chemicals
in the aquatic environment”.
Tabak and Bunch, 1970 “Steroid hormones as water pollutants I.
Metabolism of natural and synthetic ovulation-inhibiting hormones by
microorganisms of activated sludge and primary settled sewage”.
Tabak et al., 1981 “Steroid hormones as water pollutants II. Studies
on the persistence and stability of natural urinary and synthetic
ovulation-inhibiting hormones in treated and treated wastewaters”.
Even earlier studies focused on the potential impacts on soil of anti-
biotics and steroids present in manure resulting from medicated feed.
These began in the 1950s and 1960s; see the references cited in:
Warman and Thomas, 1981 “Chlortetracycline in soil amendedwith
poultry manure”.
Gregers-Hansen, 1964 “Decomposition of diethylstilboestrol in soil”.
Knight, 1980 “Estrogens administered to food producing animals:
environmental considerations”.
Broom et al., 1961 “The stability of hexoestrol in soil and its uptake
by plants”.
Coordinated responses in Europe to PiE began in the early 2000s:
CSTEE, 2001 “Opinion on: Draft CPMP Discussion Paper on Environ-
mental Risk Assessment ofMedicinal Products for HumanUse [Non-Ge-
netically Modiﬁed Organism (Non-GMO) Containing]”.
The ﬁrst formal coordinated examination of PiE in the U.S. was the
Federal InteragencyWorking Group on Pharmaceuticals in the Environ-
ment (PiE), which was formed in September 2004 (but not formally
chartered until 2006) under the Toxics and Risk Subcommittee,
Committee on Environment and Natural Resources (CENR), National
Science and Technology Council (NSTC). An external report, however,
was not released; see reference cited in:
USGAO, 2011 “Environmental Health: Action Needed to Sustain
Agencies' Collaboration on Pharmaceuticals in Drinking Water”.
4.5. Milestones and landmarks involving jargon, terms, and acronyms
pertinent to PiE
This section presents some of the terms that are unique to PiE (or
that have become closely associated with PiE). These are useful in
facilitating better-targeted literature searches. Summarized here is a
chronology of the emergence of these terms in the published literature,
which serve as milestones marking the evolution of the ﬁeld.
4.5.1. Expressions and acronyms
The many technical facets, issues, and concerns surrounding the
expansive topic of PiE cannot be cleanly retrieved from the published
archived and gray literatures because it is entangled with numerous
other ﬁelds of investigation that share most of the same technical ver-
nacular and jargon. This problem was a major driver for creation of
the curated USEPA PPCPs bibliographic database that was used for this
study. To ensure wide but pertinent coverage by literature searches, a
major strategy is to use search terms that are relatively unique to the
PiE topic or that deal with issues that intersect with PiE. Summarized
below is a brief history behind the emergence of some of these terms
and expressions in the published literature - while recognizing that
there are many others:
PiE (or PIE) [pharmaceuticals in the environment]
PPCPs (or PPCP) [pharmaceuticals and personal care products]
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EDC [endocrine-disrupting compound]
TrOC (also TOrC) [trace organic chemical]
Micro-contaminant, micro-pollutant, micro-constituent
Emerging (e.g., Contaminants of emerging concern [CECs], Emerging
contaminants, Emerging pollutants)
Non-target (or non-targeted)— in reference to chemical analysis or
environmental monitoring
Pseudo-persistent (or pseudo-persistence)
4.5.1.1. The expression “pharmaceuticals in the environment”. The ﬁrst ar-
ticles to use the expression “pharmaceuticals in the environment” (or
the German “Arzneimittel in der Umwelt” or “Arzneimittelwirkstoffe
in der Umwelt”) appeared in 1998–2000, including:
Ayscough et al., 2000 “Review of Human Pharmaceuticals in the
Environment”.
BLAC, 1999 “Arzneimittel in der Umwelt: Konzept für ein
Untersuchungsprogramm [Pharmaceuticals in the environment —
plan for a study program]”.
Christensen, 1998 “Pharmaceuticals in the Environment–A Human
Risk?”
Daughton and Ternes, 1999 “Pharmaceuticals and personal care
products in the environment: Agents of subtle change?”
Kratz et al., 2000 “Arzneimittelwirkstoffe in der Umwelt [Medication
Active Ingredients in the Environment]”.
Landesumweltamt Brandenburg (LUA), 1999 “Humanarzneimittel
in der Umwelt: Erhebung von Humanarzneimittelmengen im Land
Brandenburg 1999 [Human pharmaceuticals in the environment:
Collection of human medicinal amounts in the state of Brandenburg in
1999]”.
Schecker et al., 1998 “Arzneimittel in der Umwelt: Elimination des
Zytostatikums Ifosfamid während der simulierten Zersetzung von
Hausmüll im Labormaßstab [Pharmaceuticals in the Environment:
Elimination of the antineoplastic agent ifosfamide in a laboratory-scale
waste bioreactor]”.
4.5.1.2. PiE (or PIE). The ﬁrst paper to use the acronym PiE (or PIE)
appeared in 2002:
Dietrich et al., 2002b “Hot Spot Pollutants: Pharmaceuticals in the
Environment”.
The term was used in a number of conference presentations and
reports as early as 2005, for example:
Mastrocco, 2005 “Pharmaceuticals in the Environment (PIE):
Assessing Risk to Human Health”.
Park, 2005 “Pharmaceuticals in the Environment and Management
Approaches in Korea”.
Buzby, 2006 “Pharmaceuticals in the environment — a review of
PhRMA initiatives”.
Buzby and Meyerhoff, 2007 “Pharmaceutical Research and
Manufacturers of America: Research on Pharmaceuticals in the
Environment”.
Daughton and Ruhoy, 2007 “Pharmaceuticals in the Environment—
Why Should Anyone Care?”
But after 2002, PiE was not really used again in the peer reviewed
literature until 2007:
Khetan and Collins, 2007 “Human Pharmaceuticals in the Aquatic
Environment: A Challenge to Green Chemistry”.
Robinson et al., 2007 “Trends in the detection of pharmaceutical
products, and their impact and mitigation in water and wastewater in
North America”.
And showing its continued use, PiE has appeared in many articles,
such as more recently in:
Rastogi et al., 2015 “A sustainable chemistry solution to the presence
of pharmaceuticals and chemicals in the aquatic environment - the
example of re-designing β-blocker Atenolol”.Straub, 2016 “Aquatic environmental risk assessment for human use
of the old antibiotic sulfamethoxazole in Europe”.
Note, however, that outside the published literature, the term PiE
was already in use as early as the late 1990s. For example, the Pharma-
ceutical Research and Manufacturers of America (PhRMA) had created
its internal “Task Force on Pharmaceuticals in the Environment (PIE)”
in 1999; see discussions in:
Buzby, 2006 “Pharmaceuticals in the environment — a review of
PhRMA initiatives”.
Buzby and Meyerhoff, 2007 “Pharmaceutical Research and
Manufacturers of America: Research on Pharmaceuticals in the
Environment”.
Goldhammer, 2008 “Pharmaceuticals in the Nation's Drinking
Water: assessing potential risks and actions to address the issue”.
It was also used by the U.S. Federal Interagency Working Group on
Pharmaceuticals in the Environment (PiE), which was formed in
September 2004 (but not formally chartered until 2006) under the
Toxics and Risk Subcommittee, Committee on Environment and Natural
Resources (CENR), National Science and Technology Council (NSTC);
see the discussion in:
USGAO, 2011 “Environmental Health: Action Needed to Sustain
Agencies' Collaboration on Pharmaceuticals in Drinking Water”.4.5.1.3. PPCPs. The term “pharmaceuticals and personal care products”
(PPCPs) was introduced to the literature in 1999, when it was ﬁrst
coined:
Daughton and Ternes, 1999 “Pharmaceuticals and personal care
products in the environment: Agents of subtle change?”
Its use by others in the published literature began 2 years later, in
2001:
Boyd and Grimm, 2001 “Occurrence of Pharmaceutical
Contaminants and Screening of Treatment Alternatives for
Southeastern Louisiana”.
Drewes et al., 2001 “Occurrence of iodinated X-ray contrastmedia in
domestic efﬂuents and their fate during indirect potable reuse”.
Osemwengie and Steinberg, 2001 “On-site solid-phase extraction
and laboratory analysis of ultra-trace synthetic musks in municipal
sewage efﬂuent using gas chromatography-mass spectrometry in the
full-scan mode”.
Clearly, PPCPs cover a more expansive spectrum of consumer
chemicals since it includes personal care products.4.5.1.4. PhACs. The term PhACs (pharmaceutically active compounds)
ﬁrst appeared in 1998 and 2000, followed by several other uses in 2001:
Sedlak, 1998 “Transport and Transformation of Antibiotics and
Hormones in the Aquatic Environment”.
Sedlak et al., 2000 “Understanding Microcontaminants in Recycled
Water”.
Heberer et al., 2001b “Occurrence and Fate of Pharmaceuticals
During Bank Filtration – Preliminary Results from Investigations in
Germany and the United States”.
Heberer et al., 2001a “Removal of pharmaceutical residues and other
persistent organics frommunicipal sewage and surface waters applying
membrane ﬁltration”.
Sedlak and Pinkston 2001 “Factors Affecting the Concentrations of
Pharmaceuticals Released to the Aquatic Environment”.
Other variants have been coined but are infrequently used. One
example is “PhCs” (pharmaceuticals), which was ﬁrst used in a poster
presentation in 2007 and for the ﬁrst time in the published literature
in 2010:
Kleywegt et al., 2007 “Pharmaceuticals and personal care products in
the Canadian environment: research and policy directions”.
Verlicchi et al., 2010 “Management of hospitalwastewaters: the case
of the efﬂuent of a large hospital situated in a small town”.
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A number of other terms and acronyms serve to classify chemical
contaminants according to a variety of parameters or characteristics,
such as according to biological effects (e.g., “endocrine-disrupting com-
pound/chemical” — EDC), relative concentration in the environment
(e.g., trace levels), or novelty (e.g., any of the various expressions
using the adjective “emerging”). These aspects of chemical contami-
nants in the environment often involve pharmaceuticals.
4.5.2.1. EDCs. EDCs (or the initially less controversial “hormonally active
agent” — HAA) as an acronym for the discrete ﬁeld of study made its
entry to the general literature after theWingspread Conference inWis-
consin (1991):
ArizonaWater Resource, 2000 “Endocrine disrupters inwater:What
are EDs? What risks do they pose?”
Hotchkiss et al., 2008 “FifteenYears after “Wingspread”—Environmental
Endocrine Disrupters and Human and Wildlife Health: Where We are
Today and Where We Need to Go”.
EDCs serve as one of themany links between PPCPs and other classes
of pollutants. Note, however, that the concerns with EDCs have their
roots with research that extends back into the 1930s when estrogenic
or androgenic activity was noted for various synthetic chemicals, for
example:
Dodds et al., 1938 “OEstrogenic Activity of Certain Synthetic
Compounds”.
Schueler, 1946 “Sex Hormonal Action and Chemical Constitution”.
Stob, 1956 “Fecal Elimination of Hormones in Sheep and Cattle
Treated with Synthetic Estrogens”.
4.5.2.2. Uptake and bioconcentration by biota. There are examples of
other properties of drugs that were noted many decades before PiE
began to emerge as a cohesive, discrete concern of its own.One example
is the fact that drugs (i.e., antibiotics and veterinary hormones) can be
taken up from the soil by plants, translocated through their tissues,
and sometimes bioconcentrated. This was shown several decades be-
fore concerns with the environmental fate of drugs emerged:
Pramer, 1953 “Observations of the uptake and translocation of ﬁve
actinomycete antibiotics by cucumber seedlings”.
Stokes, 1954 “Uptake and translocation of griseofulvin by wheat
seedlings”.
Crowdy et al., 1956 “The Translocation of Antibiotics in Higher
Plants: II. The movement of griseofulvin in broad bean and tomato”.
Crowdy and Jones, 1956 “The Translocation of Sulphonamides in
Higher Plants: I. Uptake and Translocation in Broad Beans”.
Gregers-Hansen, 1964 “The uptake by plants of diethylstilboestrol
and of its glucuronide”.
Similarly, the uptake and tissue distribution of APIs had been long
studied in ﬁsh but primarily with respect to their therapeutic use
(e.g., aquaculture). It was not until the mid-2000s that attention began
to emerge regarding the possibility of uptake and bioconcentration of
trace levels of APIs in the aquatic environment by aquatic organisms
(see: Daughton and Brooks, 2011 “Active pharmaceutical ingredients
and aquatic organisms” and references cited therein). Also, since the link-
age of vulture extirpations with exposure to veterinary use of diclofenac
in the mid-2000s, interest has been growing regarding exposure to API
residues in the environment by raptors and the possible use of biomoni-
toring as a means of estimating the scope of PiE distribution and magni-
tude of API levels in the environment (e.g., see: Espín et al., 2016
“Tracking pan-continental trends in environmental contamination using
sentinel raptors—what types of samples should we use?” and references
cited therein).
4.5.2.3. Partitioning to biosolids. A topic closely allied with uptake by
plants is the partitioning of APIs to biosolids, which can then be applied
to agricultural soils. The earliest studies regarding the fate of APIs inbiosolidswere published in 1996, followed by other early articles begin-
ning in the period 1999–2002:
Rogers, 1996 “Sources, behaviour and fate of organic contaminants
during sewage treatment and in sewage sludges”.
Wilson et al., 1996 “Screening the environmental fate of organic
contaminants in sewage sludges applied to agricultural soils: 1. the
potential for downward movement to groundwaters”.
Ternes et al., 1999 “Behaviour and occurrence of estrogens in
municipal sewage treatment plants — II. Aerobic batch experiments
with activated sludge”.
Layton et al., 2000 “Mineralization of steroidal hormones by
biosolids in wastewater treatment systems in Tennessee USA”.
Holbrook et al., 2002 “Estrogen receptor agonist fate during
wastewater and biosolids treatment processes: Amass balance analysis”.
Jjemba, 2002 “The potential impact of veterinary and human
therapeutic agents in manure and biosolids on plants grown on arable
land: a review”.
Khan and Ongerth, 2002 “Estimation of pharmaceutical residues in
primary and secondary sewage sludge based on quantities of use and
fugacity modelling”.
Among these early articles were concerns expressed by the U.S. FDA
regarding environmental assessments for drugs (1998) and an NRC re-
port (2002), where biosolids are discussed in both:
USFDA, 1998 “Guidance for Industry: Environmental Assessment of
Human Drug and Biologics Application”.
Committee on Toxicants and Pathogens in Biosolids Applied to Land
et al., 2002 “Biosolids applied to land: Advancing standards and
practices”.
4.5.2.4. Trace analysis. The expression “trace organic chemical” (or “trace
organics”) appeared in the peer-reviewed literature as early as 1975–
1977; the usage of “trace organic” (or “trace levels”) is difﬁcult to deter-
mine because it had been used for quite some time outside of the PiE lit-
erature, and because it often occurs in PiE articles only in the references-
cited section. Among the earlier articles using this term are:
Heller et al., 1975 “Trace organics by GC/MS”.
Keith, 1976a “Identiﬁcation and Analysis of Organic Pollutants in
Water”.
Donaldson, 1977 “Trace organics in water”.
Sievers et al., 1977 “Environmental trace analysis of organics in
water by glass capillary column chromatography and ancillary
techniques: Products of ozonolysis”.
Initially, the term was infrequently used with respect to PiE issues,
appearing brieﬂy only in the early 1980s:
Waggott, 1981 “Trace organic substances in the River Lee”.
Drewes et al., 2001 “Occurrence of iodinated X-ray contrastmedia in
domestic efﬂuents and their fate during indirect potable reuse”.
Patterson et al., 2002 “Application of U.S. EPA methods to the analy-
sis of pharmaceuticals and personal care products in the environment:
Determination of cloﬁbric acid in sewage efﬂuent by GC-MS”.
The literature on trace organics is also intermixed with that which
focused on identifying “non-volatiles” (because non-volatiles had long
received little attention prior to the advent of high-performance liquid
chromatography):
Watts et al., 1984 “Identiﬁcation of non volatile organics in water
using ﬁeld desorption mass spectrometry and high performance liquid
chromatography”.
“Trace organic chemicals” was followed years later by its acronym,
“TOrCs,” an acronym that ﬁrst appeared in a series of reports published
in 2008 by the Water Environment Research Foundation (WERF); see:
Anderson, 2008 “Technical brief: trace organic compounds and
implications for wastewater treatment”.
A deﬁnition for TOrCs was proposed in 2010:
WERF, 2010 “Workshop Proceedings: Diagnostic tools to evaluate
impacts of trace organic compounds on aquatic populations and
communities”.
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Hoppe-Jones et al., 2010 “Attenuation of total organic carbon and
unregulated trace organic chemicals in U.S. riverbank ﬁltration
systems”.
Rauch-Williams et al., 2010 “The Role of Organic Matter in the Re-
moval of Emerging Trace Organic Chemicals during Managed Aquifer
Recharge”.
Confusingly, a variant of the acronym (i.e., TrOCs) ﬁrst appeared in
2010 and was subsequently widely adopted by others beginning in
2012:
Chiu and Westerhoff, 2010 “Trace Organics in Arizona Surface and
Wastewaters”.
Hübner et al., 2012 “Optimized removal of dissolved organic carbon
and trace organic contaminants during combined ozonation and
artiﬁcial groundwater recharge”.
Reungoat et al., 2012 “Ozonation and Biological Activated Carbon
Filtration of Wastewater Treatment Plant Efﬂuents”.
4.5.2.5. Micro-contaminant, micro-pollutant, micro-constituent. Perhaps
to place more emphasis on the reality that chemical contaminants are
reported at extremely low levels in environmental matrices (made pos-
sible by detection levels being pushed ever lower by continual advances
in analytical chemistry), new terms continued to emerge that reiterated
the idea of “trace organics”.
Of these three terms using iterations of “micro”, micro-pollutant
(micropollutant, micro pollutant) is the most common, ﬁrst occurring
in 1974–1985:
Water Research Centre, 1974 “A comprehensive list of polluting
substances which have been identiﬁed in various fresh waters, efﬂuent
discharges, aquatic animals and plants, and bottom sediments. COST pro-
ject 64b: Analysis of organic micropollutants in water”.
Waggott, 1981 “Trace organic substances in the River Lee”.
Fielding et al., 1981 “Organic micropollutants in drinking water”.
Micro-contaminant (microcontaminant, micro contaminant)
emerged in the PiE literature in 1985 but was not used again for over
a decade:
Aherne et al., 1985 “The role of immunoassay in the analysis of
microcontaminants in water samples”.
Richardson andBowron, 1985 “The fate of pharmaceutical chemicals
in the aquatic environment”.
Hirsch et al., 1998 “Determination of antibiotics in different water
compartments via liquid chromatography-electrospray tandem mass
spectrometry”.
Sedlak et al., 2000 “Understanding Microcontaminants in Recycled
Water”.
For the third variant, micro-constituent (microconstituent, micro
constituent), its usage began much later (in 2004) and is much less
common than the other two:
Petrovic et al., 2004 “Endocrine disrupting compounds and other
emerging contaminants in the environment: A survey on newmonitor-
ing strategies and occurrence data”.
Singh, 2006 “Assessing the sources, quantities, and trends on human
waste contamination along protected south Florida ecosystem: A
chemical tracer based study”.
WEF, 2007 “Effects ofWastewater Treatment onMicroconstituents”.
A series of European conferences in the early 1980s focused on the
larger topic of micro-pollutants in general:
Bjørseth and Angeletti, 1982 “Analysis of Organic Micropollutants in
Water”.
Angeletti and Bjørseth, 1984 “Analysis of Organic Micropollutants in
Water: Proceedings of the Third European Symposium held in Oslo,
Norway, September 19–21, 1983”.
4.5.2.6. Non-target pollutants (previously unmonitored unknowns). The
repeated discoveries of expanding numbers of chemical contami-
nants at ever-lower levels in environmental matrices (especiallywaters) introduced a quandary as to which contaminants to target
for monitoring. While making this determination inevitably prompts
many questions surrounding the assessment of risk and assignment
of overall priorities, it also leads to questions regarding what other
contaminants might still be present but have escaped notice or
detection. The desire to obtain a more complete understanding of
the chemical composition of the world to which all life is exposed
eventually led to an emphasis on “nontarget” contaminants — analytes
that had not been previouslymonitored orwhose presencewas noticed
in screenings but their identiﬁcation was not attempted or was
unsuccessful.
The term “non-target” (or non-targeted) has direct relevance to the
issue of PiE in that a growing number of APIs are detected and identiﬁed
in monitoring studies when they have not been among the suite of
chemicals speciﬁcally targeted. Non-targeted analysis has grown in use
largely because of advancements inmass spectrometry; for example see:
Ferrer and Thurman, 2003 “Liquid chromatography/time-of-ﬂight/
mass spectrometry (LC/TOF/MS) for the analysis of emerging
contaminants”.
Ferrer and Thurman, 2003 “Analysis of Emerging Contaminants”.
The desire and ability to perform non-targeted analyses (to identify
unknowns) really began in the 1970s, although it was not speciﬁcally
referred to as such — but rather as “chemical characterization”:
Keith, 1976b “Recent advances in the identiﬁcation and analysis of
organic pollutants in water”.
Kleopfer and Fairless, 1972 “Characterization of organic components
in a municipal water supply”.
Grob, 1973 “Organic substances in potable water and in its
precursor: Part I. Methods for their determination by gas-liquid
chromatography”.
These early studies were catalyzed by the growing inventories of
trace organic chemicals (primarily of industrial and agricultural origin)
reported in ambient waters; for example, see the 1970 report prepared
for the US EPA:
Davis et al., 1970 “Organic Chemical Pollution of Freshwater”.
These studies involving non-targeted analysis (whichwere forced to
rely on mass spectral libraries that were not sufﬁciently comprehen-
sive) were also limited by insufﬁcient mass resolution, spectral acquisi-
tion speed (required for full-spectrum scanning), and data acquisition,
processing, and storage. A later example (in 1994) is:
Hendriks et al., 1994 “Monitoring response of XAD-concentrated
water in the Rhine delta: A major part of the toxic compounds remains
unidentiﬁed”.
These early chemical characterization studies attempted to identify
some of themany unknown chemicals that becameevidentwith the ad-
vent of high-resolution GC and LC; many of these unmasked substances
that had been noted in prior analyses simply as unknowns (and never
suspected to be present) started to become labeled as “tentatively iden-
tiﬁed compounds”. One such study (in 1976) was among the ﬁrst to es-
tablish the presence of a drug metabolite (i.e., cloﬁbric acid) in
wastewater:
Garrison et al., 1976 “GC/MS Analysis of Organic Compounds in
Domestic Wastewaters”.
Garrison, 1977 “Analysis of organic compounds in water to support
health effects studies”.
Note that thework of Garrison et al. was preceded the year before by
several studies focused on the occurrence of radionuclides used in nu-
clearmedicine, reﬂecting the emerging realization that drug substances
could enter sewers as a result of their routine use:
Dielman, 1978 “A report on hospital efﬂuent problems with low
level radionuclides”.
Gesell et al., 1975 “Nuclear medicine environmental discharge
measurement. Final report”.
Sodd et al., 1975 “Concentrations of the Medically Useful
Radionuclides, Technetium-99m and Iodine-131 at a Large Metropoli-
tan Waste Water Treatment Plant”.
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sible because of the continual advancements in mass spectral analysis
(e.g., see: Wode et al., 2015 “Search for over 2000 current and legacy
micropollutants on a wastewater inﬁltration site with a UPLC-high
resolution MS target screening method”). The ease and speed of
compound identiﬁcation made possible by the growing power of mass
spectrometry now serves to blur the distinction between targeted and
non-targeted analysis.
Non-targeted monitoring or screening of waters was being per-
formed more routinely in the 1990s and early 2000s for a variety of
chemicals, including the non-target identiﬁcation of pharmaceuticals
and personal care products:
Franke et al., 1995 “Organic compounds as contaminants of the Elbe
River and its tributaries. Part II: GC/MS screening for contaminants of
the Elbe water”.
Paxéus, 1996 “Organic pollutants in the efﬂuents of large
wastewater treatment plants in Sweden”.
Bester et al., 1998 “Results of non target screening of lipophilic
organic pollutants in the German bight II: Polycyclic musk fragrances”.
Weigel et al., 2001 “Newmethod for rapid solid-phase extraction of
large-volumewater samples and its application to non-target screening
of North Sea water for organic contaminants by gas chromatography-
mass spectrometry”.
Dsikowitzky et al., 2002 “Distribution of polycyclic musks in water
and particulate matter of the Lippe River (Germany)”.
Oros et al., 2003 “Surveillance for previously unmonitored organic
contaminants in the San Francisco Estuary”.
These studies were partly catalyzed by a growing recognition that a
large fraction of the organic contaminants that occur in waters had yet
to be identiﬁed by targeted analysis; for example, see:
Hendriks et al., 1994 “Monitoring response of XAD-concentrated
water in the Rhine delta: A major part of the toxic compounds remains
unidentiﬁed”.
Daughton, 2003a “Cradle-to-cradle stewardship of drugs for
minimizing their environmental disposition while promoting human
health. I. Rationale for and avenues toward a green pharmacy”.
Daughton, 2005 “Emerging chemicals as pollutants in the
environment: a 21st century perspective”.
Recognition of an “iceberg” scenario emerged, where growing num-
bers of unique but previously unrecognized chemicals may occur in the
environment at ever-lower (and previously unmeasurable concentra-
tions). Suspicions also continue to emerge that those chemical contam-
inants that remain unidentiﬁed may be responsible for signiﬁcant
portions of unexplained stress in biological systems:
Daughton, 2013 “Pharmaceuticals in the Environment: Sources and
Their Management”.
The utility of non-targeted analysis for PiE did not begin to receive
concerted attention until the early 2000s. But identiﬁcation of non-
target analytes was intentionally omitted from the ﬁrst large-scale
monitoring study involving PiE, published by the USGS in 2002. None-
theless, this seminal study was probably largely responsible for catalyz-
ing heightened interest in non-targeted monitoring:
Kolpin et al., 2002 “Pharmaceuticals, hormones, and other organic
wastewater contaminants in U.S. streams, 1999–2000: a national
reconnaissance”.
The ﬁrst studies to stress the value of non-targeted analysis and to
begin showing its application in identifying certain non-targeted APIs
began to appear only in 2002–2003:
Khan, 2002 “Occurrence, behaviour and fate of pharmaceutical
residues in sewage treatment”.
Pedersen et al., 2003 “Xenobiotic organic compounds in runoff from
ﬁelds irrigated with treated wastewater”.
Ricking et al., 2003 “Molecular markers of anthropogenic activity in
sediments of the Havel and Spree Rivers (Germany)”.
Kronimus et al., 2004 “Anthropogenic organic contaminants in
sediments of the Lippe river, Germany”.Soliman et al., 2004 “Rapid gas chromatography-mass spectrometry
screening method for human pharmaceuticals, hormones, antioxidants
and plasticizers in water”.
Pedersen et al., 2005 “Human Pharmaceuticals, Hormones, and
Personal Care Product Ingredients in Runoff from Agricultural Fields
Irrigated with Treated Wastewater”.
Non-targeted analysis began to receive attention for use in biological
effects-directed characterization of wastewaters in 2004:
Heisterkamp et al., 2004 “Bioassay-directed chemical analysis
utilizing LC–MS: A tool for identifying estrogenic compounds in water
samples?”
Over the last 10 years, the application of non-target analysis tomore
comprehensive characterization of environmental samples for pharma-
ceuticals (as well as other emerging chemicals) has grown dramatically
— often catalyzed by the concerns surrounding PiE:
Bletsou et al., 2015 “Targeted and non-targeted liquid
chromatography-mass spectrometric workﬂows for identiﬁcation of
transformation products of emerging pollutants in the aquatic
environment”.
Diaz et al., 2012 “Target and non-target screening strategies for or-
ganic contaminants, residues and illicit substances in food, environmen-
tal and human biological samples by UHPLC-QTOF-MS”.
Herrera-Lopez et al., 2014 “Simultaneous screening of targeted and
non-targeted contaminants using an LC-QTOF-MS system and automat-
ed MS/MS library searching”.
Hogenboom et al., 2009 “Accurate mass screening and identiﬁcation
of emerging contaminants in environmental samples by liquid
chromatography-hybrid linear ion trap Orbitrap mass spectrometry”.
Hug et al., 2014 “Identiﬁcation of novel micropollutants in
wastewater by a combination of suspect and nontarget screening”.
Ibáñez et al., 2008 “Rapid non-target screening of organic pollutants
in water by ultraperformance liquid chromatography coupled to time-
of-light mass spectrometry”.
Martínez Bueno et al., 2007 “Application of Liquid Chromatography/
Quadrupole-Linear Ion Trap Mass Spectrometry and Time-of-Flight
Mass Spectrometry to the Determination of Pharmaceuticals and Relat-
ed Contaminants in Wastewater”.
Schwarzbauer and Ricking, 2010 “Non-target screening analysis of
river water as compound-related base for monitoring measures”.
Schymanski et al., 2015 “Non-target screening with high-resolution
mass spectrometry: critical review using a collaborative trial on water
analysis”.
Zedda and Zwiener, 2012 “Is nontarget screening of emerging
contaminants by LC-HRMS successful? A plea for compound libraries
and computer tools”.
4.5.2.7. Transformation products (TPs). An important aspect of PiE is that
the chemical products of various transformation processes can often
possess biological activity of their own, with many of these products
being more potent than their parent structures. While this might be
obvious for drugs designed as pro-drugs (where the parent drug
might require metabolic transformation to produce the active form),
this can also be true for various process pathways in the environment
(both biotic and abiotic) that can structurally transform parent
structures, including microbial action (biotransformation, biodegrada-
tion), sunlight (photolysis, photodegradation, phototransformation),
and chemical (e.g., disinfection byproducts created by oxidative
treatment). The study of transformation processes and pathways has
long been an integral aspect of environmental toxicology. So tracing
its roots within the PiE literature is not straightforward, primarily
because of the numerous aspects of transformation and the fact that
transformation has many distinct threads throughout the published
PiE literature.
Study of the transformation of APIs was originally directed at its
relevance in reducing the biological activity of the parent structures.
This served as a focus in the study of waste treatment and in studies
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a process that held potential to create new and sometimes more toxic
and persistent byproducts and yet further complicate the assessment
of risk (Escher and Fenner, 2011 “Recent Advances in Environmental
Risk Assessment of Transformation Products”). This eventually became
yet another aspect of the expansive topic of emerging contaminants
(see Section 4.5.3.1). Also note that the topic of API metabolic conjuga-
tion (see Section 4.5.3.2) is related to transformation in the sense that
API glucuronides are excreted as endogenous products of metabolism
and can then undergo transformation back to their parent APIs.
Perhaps the key concern posed by the various transformation pro-
cesses and their actions on an already large galaxy of APIs is the large
uncertainty imposed on assessing risk because of the potential for one
or multiple byproducts from each individual API. And the vast majority
of these byproducts have yet to be characterized. This, in turn, has
served to catalyze yet more interest in non-targeted monitoring.
The concerns regarding transformation products (often abbreviated
TPs) began to attract attention in 2007–2008:
Barceló, 2007 “Pharmaceutical-residue analysis”.
Farré et al., 2008 “Fate and toxicity of emerging pollutants, their
metabolites and transformation products in the aquatic environment”.
Kosjek et al., 2007 “Mass spectrometry for identifying
pharmaceutical biotransformation products in the environment”.
Kosjek and Heath, 2008 “Applications of mass spectrometry to
identifying pharmaceutical-transformation products in water
treatment”.
Kümmerer, 2007 “Sustainable from the very beginning: rational
design of molecules by life cycle engineering as an important
approach for green pharmacy and green chemistry”.
Sharma, 2008 “Oxidative transformations of environmental
pharmaceuticals by Cl2, ClO2, O3, and Fe(VI): Kinetics assessment”.
Use of the acronym “TPs” began in 2004–2005:
Oppel et al., 2004 “Leaching behaviour of pharmaceuticals in soil-
testing-systems: a part of an environmental risk assessment for ground-
water protection”.
Agüera et al., 2005 “Application of time-of-ﬂight mass spectrometry
to the analysis of phototransformation products of diclofenac in water
under natural sunlight”.
Lofﬂer et al., 2005 “Environmental Fate of Pharmaceuticals inWater/
Sediment Systems”.
Reviews dedicated to TPs only began to appear in the last couple of
years:
Evgenidou et al., 2015 “Occurrence and removal of transformation
products of PPCPs and illicit drugs in wastewaters: A review”.
Hübner et al., 2015 “Evaluation of the persistence of transformation
products fromozonation of trace organic compounds— a critical review”.
Petrie et al., 2015 “A review on emerging contaminants in
wastewaters and the environment: current knowledge, understudied
areas and recommendations for future monitoring”.
Among the few, more speciﬁc and rather unique terms for TPs in-
clude “degradate,”which became an alternative for “degradation prod-
uct” in the early 1980s. But it did not begin experiencingmore common
usage until the 1990s:
Bull et al., 1984 “Fate of avermectin B1a in soil and plants”.
Bergh et al., 1990 “High-performance liquid chromatographic
analysis of trimethoprim in the presence of its degradation products”.
Gruber et al., 1990 “Mobility of avermectin B1a in soil”.
Halley et al., 1993 “Environmental effects of the usage of avermectin
in livestock”.
4.5.3. Concepts fostered by PiE
4.5.3.1. “Emerging” — emerging contaminants, emerging pollutants, con-
taminants of emerging concern (CECs). The term “emerging” has been
frequently applied to PiE, primarily with the intention to frame it as a
topic that has escaped prior notice or that has not been sufﬁcientlyrecognized as a potential concern; an added motivation behind use
of the term when discussing PiE may also be in attracting attention
or eliciting concern. At times, the topics of emerging contaminants
and PiE have been narrowly conﬂated as one and the same. The
term “emerging” has also brought attention to the corollary that
APIs as environmental contaminants have been largely unregulated.
In the popular press, use of the word “emerging” has possibly sought
to inject cause for some alarm, similarly to its use in describing the
identiﬁcation of “emerging” pathogens or pathogens with emerging
resistance.
Perhaps the ﬁrst article to use the term emerging with respect to
chemical contaminants was published in 1999:
NRC, 1999 “Identifying Future Drinking Water Contaminants”.
Brief mention of emerging was also made in:
Sedlak et al., 2000 “Understanding Microcontaminants in Recycled
Water”.
Perhaps the ﬁrst formal research program devoted to emerging
contaminants was launched by the USGS. It was ﬁrst referenced in the
published literature in 2000 as the “Emerging Contaminants Program”:
Meyer et al., 2000 “Use of radioimmunoassay as a screen for
antibiotics in conﬁned animal feeding operations and conﬁrmation by
liquid chromatography/mass spectrometry”.
The USGS also established a web page for their emerging contami-
nants program in the early 2000s; the current URL for this web page
is: http://toxics.usgs.gov/regional/emc/.
The ﬁrst conference whose focus was on emerging contaminants
was organized by the National Ground Water Association, in 2000:
NGWA, 2000 (7–8 June) “Emerging Issues Conference -
pharmaceuticals - endocrine disrupting chemicals - pesticides -
arsenic and radon”.
The ﬁrst focused discussion and attempt to formally deﬁne “emerg-
ing” pollutants was published in 2001:
Daughton, 2001a “Emerging pollutants, and communicating the
science of environmental chemistry and mass spectrometry:
pharmaceuticals in the environment”.
An historical perspective on emerging contaminants is presented by
Halden:
Halden, 2015 “Epistemology of Contaminants of Emerging Concern
and Literature Meta-analysis”.
Use of “emerging” in the scientiﬁc literaturewas quickly followed by
its adoption in the popular press, where the ﬁrst news coverage
appeared in 2000:
“traces of 70 ‘emerging contaminants’ — substances that are not
now considered environmental hazards but are facing growing
scrutiny …”:
Carr, 2000 “Flush with drugs: Waterways examined for potential
risks posed by medicines released down drains”.
“government agencies concerned with water quality in the United
States and professional organizations serving the water and waste-
water communities are beginning to acknowledge PPCPs as an
emerging environmental issue…”:
Greene, 2000 “Controversy swirls around toilet-to-tap project”.
“Organizers said it was the ﬁrst time scientists have gathered to ad-
dress the topic in North America — itself a sign of just how little at-
tention has been paid to the emerging environmental concerns
posed by products such as antibiotics, psychiatric drugs, hormones,
animal-feed additives and synthetic fragrances…”:
Hall, 2000 “Makeup, medication may pollute waterways”.
“Water pollution by drugs ‘is a newly emerging issue…’”:
Raloff, 2000b “More waters test positive for drugs”.
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— some being more obscure, such as EPOCs (“emerging pollutants of
concern”), whose use began in 2005:
Crook et al., 2005 “Status and Role of Water Reuse: An International
View”.
Daughton, 2006 “Emerging Pollutants - Questions, Challenges, and
the Future”.
Singh, 2006 “Assessing the sources, quantities, and trends on human
waste contamination along protected south Florida ecosystem: A
chemical tracer based study”.
Daughton and Ruhoy, 2007 “Pharmaceuticals in the Environment—
Why Should Anyone Care?”
Daughton and Ruhoy, 2010 “Pharmaceuticals in the Environment -
Why Should We Care?”
Regardless of the original intentions of the descriptor “emerging”, its
continued use [now extending into 2016, e.g. see: Álvarez-Torrellas
et al., 2016 “Comparative adsorption performance of ibuprofen and
tetracycline from aqueous solution by carbonaceous materials”; Li
et al., 2016 “Can environmental pharmaceuticals be photocatalytically
degraded and completely mineralized in water using g-C3N4/TiO2
under visible light irradiation?—Implications of persistent toxic inter-
mediates”; Patiño et al., 2016 “Pre-concentration of nalidixic acid
through adsorption-desorption cycles: adsorbent selection and model-
ling”; Rao et al., 2016 “Degradation of Ibuprofen by a synergistic UV/
Fe(III)/Oxone Process”; Russo et al., 2016 “Direct photolysis of
benzoylecgonine under UV irradiation at 254 nm in a continuous ﬂow
microcapillary array photoreactor”] poses questions regarding itsmean-
ing or utility given the sizeable pre-existing published PiE literature that
now extends back decades. Does “emerging” still add value to this topic
or should it be reserved for those environmental contaminants or con-
cerns that meet the original intentions articulated in 2001:
Daughton, 2001a “Emerging pollutants, and communicating the
science of environmental chemistry and mass spectrometry:
pharmaceuticals in the environment”.
Questions regarding the usefulness of the term become even more
germane when published articles begin to refer to pollutants known
for centuries as having been “emerging” during their time. With the es-
calating growth of journals, it was inevitable that “emerging contami-
nants” would eventually be used as the name for a journal (in
December 2014): http://www.keaipublishing.com/en/journals/
emerging-contaminants/
Newways to express the idea of “emerging” continue to appear. One
communicates from the perspective of exposure rather than the stress-
or. An example is the expression “new” or “distinctive” exposure:
Klupinski et al., 2015 “Identiﬁcation of New and Distinctive
Exposures from Little Cigars”.
4.5.3.2. Processes particularly important to the fate of APIs in the
environment: pseudo-persistence and de-conjugation. Some new terms
have emerged as a direct result of the PiE topic. One example is “pseu-
do-persistence.” The fact that certain chemicals (even those with short
environmental half-lives such asAPIs) cannonetheless establish a contin-
ual presence in certain domains of the environment was a concept that
was introduced in 2002–2003 and termed “pseudopersistence”:
Daughton, 2002 “Environmental stewardship and drugs as
pollutants”.
Daughton, 2003a “Cradle-to-cradle stewardship of drugs for
minimizing their environmental disposition while promoting human
health. I. Rationale for and avenues toward a green pharmacy”.
APIs serve as the prototypical example of pseudopersistent
chemicals given that their major route of entry to the environment is
via sewage, which serves as a means for continual replenishment of
what would otherwise be continuously diminishing levels. APIs have
therefore served to show that chemical half-life (as a measure of chem-
ical stability and resistance tomicrobial degradation and other environ-
mental transformation processes) is not the only driver that dictates theubiquitous presence of chemicals in the environment (such as inherent
resistance to chemical transformations).
This concept has since been discussed in more depth and a simpler
alternative proposed (i.e., “continuously present” or, simply, “continu-
ous presence”):
Mackay et al., 2014 “The role of persistence in chemical evaluations”.
Other terms unique to PiE have also emerged. One in particular —
“EPPP” (Environmental Persistent Pharmaceutical Pollutants) — was
proposed at a 2010 meeting involving the Strategic Approach to Inter-
national Chemicals Management (SAICM) by the International Society
of Doctors for the Environment (ISDE):
International Society of Doctors for the Environment (ISDE), 2010
“Strategic Approach to International Chemicals Management:
Nomination of emerging policy issues for consideration by the
International Conference on Chemicals Management at its third
session”.
It is important to recognize that some new terms, such as EPPP, may
only serve to add confusion to the literature. In this particular case, few
APIs meet the conventional criteria for being environmentally persis-
tent (one example being iodinated X-ray contrast agents). Creation of
new acronyms can clearly be misleading. The long-established POPs
(persistent organic pollutants) would seem to encompass EPPPs, even
though their scopes would hardly intersect.
One process that has been particularly germane to PiE — and which
can also play a secondary role in environmental persistence — is the
process of metabolic conjugation, a pathway for detoxiﬁcation and ex-
cretion of APIs from humans and animals. Some metabolic conjugates
are reversible; these are sometimes also called interconvertible conju-
gates. The importance of reversible metabolic conjugates of APIs is
that they can be recycled back to the parent API by hydrolysis or cleav-
age of particular bonds— a process called deconjugation. For drugs that
are extensively excreted as reversible conjugates, the conjugates can
possibly serve as hidden reservoirs of the parent APIs in the
environment.
Assessing the magnitude or signiﬁcance of conjugate excretion and
subsequent deconjugation has proved difﬁcult with respect to PiE and
persistence. After arriving in the inﬂuent to sewage treatment plants
in conjugated forms, subsequent deconjugation might be the cause of
higher levels of free, unconjugated APIs in the treated efﬂuent com-
pared with those measured in the raw inﬂuent; for further discussion
and many examples of this phenomenon see:
Daughton, 2014b “Eco-Directed Sustainable Prescribing: Feasibility
for ReducingWater Contamination by Drugs” [see Table S-3 therein: Ex-
amples of “apparent increased concentrations” (negative removals), de-
conjugation, or presence of conjugates of various non-steroidal APIs
during sewage treatment].
The possible role and importance of deconjugation in the regenera-
tion of the parent API was ﬁrst recognized for various steroid hormones
— in a ﬂurry of articles during 1998–2000, including:
Baronti et al., 2000 “Monitoring natural and synthetic estrogens at
activated sludge sewage treatment plants and in a receiving river
water”.
Desbrow et al., 1998 “Identiﬁcation of estrogenic chemicals in STW
efﬂuent. 1. Chemical Fractionation and in vitro biological screening”.
Panter et al., 1999 “Transformation of a non-oestrogenic steroidme-
tabolite to an oestrogenically active substance by minimal bacterial
activity”.
Ternes et al. 1999 “Behaviour and occurrence of estrogens in
municipal sewage treatment plants – II. Aerobic batch experiments
with activated sludge”.
Tyler and Routledge, 1998 “Natural and anthropogenic
environmental oestrogens: the scientiﬁc basis for risk assessment;
Oestrogenic effects in ﬁsh in English rivers with evidence of their
causation”.
Wegener et al., 1999 “Vorkommen und Verhalten von natürlichen
und synthetischen Östrogenen und deren Konjugate in der aquatischen
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their conjugates in the aquatic environment]”.
The possible role of de-conjugation for non-steroidal, small-
molecular drugs initially received comparatively less attention, with a
few of the ﬁrst articles also appearing in 1998–1999, including:
Möhle et al., 1999 “Untersuchungen zum Abbau von Pharmaka in
kommunalen Kläranlagen mit HPLC-Electrospray-Massenspektrometrie
[Examination of the degradation of drugs in municipal sewage plants
using liquid chromatography-electrospray mass spectrometry]”.
Sattelberger, 1999 “Arzneimittelrückstände in der Umwelt –
Bestandsaufnahme und Problemdarstellung [Pharmaceutical residues
in the environment— An inventory and problem representation]”.
Ternes et al., 1998 “Methods for the determination of neutral drugs
as well as betablockers and β2-sympathomimetics in aqueous matrices
using GC/MS and LC/MS/MS”.
4.5.3.3. APIs as monitoring tools: source tracking of sewage and human ac-
tivities (indicators, tracers, markers, surrogates, sentinel chemicals). Not
until the late 1990s and early 2000s did APIs and their transformation/
metabolic products become recognized for their possible utility as
tools for tracking the origin and fate of sewage in the environment;
this served to augment the long-established use of microorganisms
(and their genetic materials), fecal sterols, consumer products
(e.g., caffeine, polyethoxylates, ﬂuorescent brighteners, and synthetic
fragrances), and certain inorganic substances as extended indicators
or proxies for detecting the presence of human waste in natural waters.
Examples include:
Chen et al., 2002 “Determination of caffeine as a tracer of sewage
efﬂuent in natural waters by on-line solid-phase extraction and liquid
chromatography with diode-array detection”.
Heberer, 2002b “Tracking persistent pharmaceutical residues from
municipal sewage to drinking water”.
Möller et al., 2000 “Anthropogenic gadolinium as a conservative
tracer in hydrology”.
Seiler et al., 1999 “Caffeine and pharmaceuticals as indicators of
waste water contamination in wells”.
Concerted attention to the use of APIs as indicators, tracers, or track-
ing agents took several more years to develop — in the mid-2000s:
Fono and Sedlak, 2005 “Use of the Chiral Pharmaceutical Propranolol
to Identify Sewage Discharges into Surface Waters”.
Fono and Sedlak, 2007 “A simple method for the measurement of
organic iodine in wastewater and surface water”.
Glassmeyer et al., 2005 “Transport of Chemical and Microbial
Compounds from Known Wastewater Discharges: Potential for Use as
Indicators of Human Fecal Contamination”.
Heim et al., 2004 “Monitoring of waste deposit derived groundwater
contamination with organic tracers”.
Katz and Grifﬁn, 2007 “Using chemical and microbiological
indicators to track the impacts from the land application of treated
municipal wastewater and other sources on groundwater quality in a
karstic springs basin”.
Around the same time as the development of source tracking using
APIs, another new application was proposed involving the monitoring
of API levels in sewage. Themonitoring of speciﬁc drug residues in sew-
age (initially, residues of illicit drugs) was proposed for reconstructing
community-wide drug usage rates (Daughton, 2001 “Illicit drugs in
municipal sewage: Proposed new non-intrusive tool to heighten public
awareness of societal use of illicit/abused drugs and their potential for
ecological consequence”); surprisingly, illicit drugs had been largely
omitted from the PiE discussion, even with respect to their potential
for ecological effects. This approach was ﬁrst reduced to practice in
2005 by Zuccato et al. and continues to attract growing interest:
Zuccato et al., 2005 “Cocaine in surface waters: A new evidence-
based tool to monitor community drug abuse”.
The approach became known initially (in 2008) as “sewage
epidemiology” or “sewage-based epidemiology” (Zuccato et al., 2008“Estimating Community Drug Abuse by Wastewater Analysis”; Frost
and Grifﬁths, 2008 “Introduction to sewage epidemiology and the
wastewater system”) and as “sewage forensics” (Kasprzyk-Hordern
et al., 2010 “Enantiomeric analysis of drugs of abuse in wastewater by
chiral liquid chromatography coupled with tandem mass spectrome-
try”), or sometimes as “community drug testing” or “community
urinalysis”. It later received amore formal name: “Forensic Epidemiolo-
gy Using Drugs in Sewage” — FEUDS (Daughton, 2011 “Illicit Drugs:
Contaminants in the Environment and Utility in Forensic
Epidemiology”). The general approach made possible for the ﬁrst time
an evidence-based means for determining normalized per capita esti-
mates of substance ﬂows in sewage (Daughton, 2001 “Illicit drugs in
municipal sewage: Proposed new non-intrusive tool to heighten public
awareness of societal use of illicit/abused drugs and their potential for
ecological consequence”).
The history behind this new tool for gauging community-wide usage
rates is presented here:
Daughton, 2011 “Illicit Drugs: Contaminants in the Environment and
Utility in Forensic Epidemiology”.
The chemical monitoring of sewage for the purpose of estimating
human consumption (or for substance-ﬂow analysis in general) has
been steadily expanding to target more types of so-called “down-the-
drain” chemicals. Surprisingly, this ﬁeld has only more recently begun
to target licit pharmaceuticals and their human metabolites as an addi-
tional approach for estimating (via back-calculation) population-wide
consumption of therapeutic medicines:
ter Laak et al., 2014 “Different compositions of pharmaceuticals in
Dutch and Belgian rivers explained by consumption patterns and
treatment efﬁciency”.
Likewise, this ﬁeld is beginning to attract interest as a tool for esti-
mating population-wide consumption of other substances of abuse,
such as alcohol and nicotine:
Reid et al., 2011 “Analysis and Interpretation of Speciﬁc Ethanol
Metabolites, Ethyl Sulfate, and Ethyl Glucuronide in Sewage Efﬂuent
for the Quantitative Measurement of Regional Alcohol Consumption”.
Mastroianni et al., 2014 “Analysis of ethyl sulfate in rawwastewater
for estimation of alcohol consumption and its correlation with drugs of
abuse in the city of Barcelona”.
Rodríguez-Álvarez et al., 2014 “Assessment of local tobacco
consumption by liquid chromatography-tandem mass spectrometry
sewage analysis of nicotine and its metabolites, cotinine and trans-3′-
hydroxycotinine, after enzymatic deconjugation”.
Tscharke et al., 2015 “Estimates of tobacco use by wastewater
analysis of anabasine and anatabine”.
In its most general sense, sewage analysis can be called “sewage
chemical-informationmining” (SCIM). One of themost recent potential
applications of SCIM is the monitoring of endogenous biomarkers of
human stress or disease for the purpose of estimating community-
wide health status:
Daughton, 2012 “Using biomarkers in sewage tomonitor community-
wide human health: Isoprostanes as conceptual prototype”.
Ryu et al., 2015 “Liquid chromatography–high resolutionmass spec-
trometrywith immunoafﬁnity clean-up for the determination of the ox-
idative stress biomarker 8-iso-prostaglandin F2alpha in wastewater”.
API monitoring in sewage continues to evolve as a tool for address-
ing additional questions. One area receiving increasing attention is the
monitoring of speciﬁc API enantiomers for thepurpose of differentiating
origins or sources. One of the ﬁrst examples (in 1999) was the use of
chiral analysis for determining the portion of API sewage loading origi-
nating from raw sewage versus treated sewage (as microbial degrada-
tion can result in alteration of enantiomeric ratios):
Buser et al., 1999 “Occurrence and Environmental Behavior of the
Chiral Pharmaceutical Drug Ibuprofen in Surface Waters and in
Wastewater”.
Poiger et al., 2003 “Occurrence and fate of organicmicropollutants in
the environment: Regional mass balances and source apportioning in
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monitoring, and computer modeling”.
Fono and Sedlak, 2005 “Use of the Chiral Pharmaceutical Propranolol
to Identify Sewage Discharges into Surface Waters”.
One question that has proved particularly refractory is determining
the relative importance of direct disposal of leftover medications to
sewerage versus excretion with respect to the levels of APIs in sewage.
Since metabolism of racemic APIs can skew the relative ratios of optical
isomers, the contribution of APIs in raw sewage that originate from
disposal could possibly be differentiated from the portion resulting
from excretion. This was ﬁrst proposed in 2007, and studies beginning
in 2012 have tried to show the utility of this approach:
Daughton, 2007 “Pharmaceuticals in the environment: sources and
their management”.
Kasprzyk-Hordern and Baker, 2012 “Estimation of community-wide
drugs use via stereoselective proﬁling of sewage”.
Emke et al., 2014 “Enantiomer proﬁling of high loads of
amphetamine and MDMA in communal sewage: A Dutch perspective”.
Petrie et al., 2016 “A new framework to diagnose the direct disposal
of prescribed drugs in wastewater— a case study of the antidepressant
ﬂuoxetine”.
4.6. The most-highly cited articles on PiE
4.6.1. Approach for bibliometrics
One of the most useful and direct ways to assess the emergence of
PiE as a concerted ﬁeld of investigation is by examining the citation
trajectories of the peer-reviewed literature. Bibliographic citations
reﬂect interest from the science community and therefore may serve
as an indirect measure of the impact or signiﬁcance of the cited papers.
Citation analysis, as part of the ﬁeld of scientometrics, will not be
discussed here. The intent in this study was merely to identify those
PiE articles that were the most highly cited at the time this paper was
prepared. This compilation of most-cited articles relevant to PiE repre-
sents the ﬁrst such attempt. The lack of prior, comprehensive compila-
tions of most-cited articles on PiE might simply be a result of the
surprising amount of time and effort required.
There was no intent to further interpret what the citation counts
might mean; there are numerous limitations to the interpretation of ci-
tation counts, many resulting from biases introduced by errors in citing
or by gratuitous citing practices. It is important, however, to recognize
that the citation counts reported here represent only a point in time
(April 2015). Over time, the citation rates of even the most highly
cited individual articles will vary. One would expect that their overall
relative rankings might change over time. Some articles currently
categorized as highly cited could eventually be displaced by others
that are currently less-cited if their rates of citation are increasing faster.
In this study, those articles that had been cited at least 200 times
were categorized as highly cited. The citationsweremined from Google
Scholar (GS), recognizing the limitations of this database, whichmay be
biased high compared with curated citation databases. Given that only
articles with the most citations were of interest, self-citations were as-
sumed to contribute proportionately less bias than for less-frequently
cited articles. Also note that citation counts are much more reliable for
journal articles than for book chapters. Books are problematic because
of the variations in how citation counts are assigned by search engines;
mis-assigned citations are common because of the confusion caused by
the complexity and variance in the formatting of reference citations for
books and because of confusion as to whether a citation belongs to an
individual chapter or to the entire respective book.
Important to note is the difﬁculty in establishing which articles
among the thousands published on PiE that have garnered the most
citations. This is not a straightforward endeavor and is quite time-
consuming. The bibliographic software application Zotero was used to
download citation counts directly from GS using the Mozilla Firefox
plug-in “Google Scholar Citations for Zotero” (https://addons.mozilla.org/en-us/ﬁrefox/addon/zotero-scholar-citations/). This was a time-
consuming task because Google restricts the frequency of access for
downloading; citation counts can only be downloaded for a limited
number of references for each cycling of the plug-in before Google
blocks all newqueries (a feature designed byGoogle to block automated
machine requests); the cycle can only be restarted within a time-out by
deleting browser cookies, responding to repeated CAPTCHA requests,
and restarting the GS plug-in. To cover all of the journal articles and
books chapters in the EndNote database required the repeated querying
of GS hundreds of cycles for all of the articles in the PPCPs bibliographic
database.
The citation data in the PPCPs bibliographic database ﬁrst had to be
imported into Zotero. The ﬁnal Zotero citation counts were then
exported into Excel so that they could be easily sorted. Once the most-
highly cited articles were identiﬁed, the counts for each article were di-
rectly veriﬁed by locating the reference in Google Scholar (GS). Exten-
sive quality checks for comprehensiveness (to ensure that all of the
highly cited articles were indeed captured) were made by performing
a large number of searches in Google Scholar and examining them for
the most highly cited articles. These searches were designed to repre-
sent a wide spectrum of facets of the overall topic of PiE to increase
the probability that a large portion of the PiE literature was being
accessed. When highly cited articles were located, the citing articles
were also assessed for their citation counts. This repetitive, iterative pro-
cess took quite a number of weeks to reach a point where no additional
articles could be found that qualiﬁed as highly cited. Surprisingly, exten-
sive forward and backward searching using a wide spectrum of key
words and terms using GS failed to locate most of the most highly
cited papers; extensive forward/backward citation searching using GS
also did not locate any highly cited articles that were not already
captured in the database. Some of the most-cited papers in the PPCPs
database were only indirectly pertinent to the PiE issue. These papers
tended to focus on antibiotic resistance and endocrine disruption and
were therefore excluded from the core set of papers considered for
being themost-cited for the PiE topic itself. An outline of themethodol-
ogy used for all of the bibliometric analyses performed in this study is
summarized in Supplementary Table S-4.
Note thatmany articles justmissed the arbitrary cut-offminimumof
200 citations. Just months later, many of the articles residing below this
cutoff would probably qualify as highly cited; some might have even
received more citations that those currently ranked at the bottom of
the most-cited. The relative rankings of the articles ranked at the top
would be expected to remain consistent for considerably longer.
4.6.2. Results
The cumulative yearly totals of journal articles and book chapters
relevant to the many facets of PiE are displayed in Supplementary
Fig. S-3. Publishing activity can be clearly seen to begin escalating in
the period 1998–2000. Through 2014, the rate of publication continued
to increase each year.
A total of 385 PiE articles were identiﬁed as having from 200 to 5424
citation counts (as of April 2015). These comprised roughly 2% of the en-
tire database. Only ﬁve book chapters or books were among the articles
identiﬁed as most cited (ranging from 202 to 738 citations each); this
must be tempered, however, by recognizing the problems faced by
search engines compiling accurate citations for books:
Damstra et al., 2002 “Global assessment of the state-of-the-science
of endocrine disruptors”.
Jelić et al., 2012 “Pharmaceuticals in drinking water”.
Joss et al., 2006 “Wastewater treatment”
Kümmerer, 2008 “Pharmaceuticals in the environment - Sources,
fate, effects, and risks”.
Sørensen, 2008 “Veterinary Medicines”.
These 385 articles are listed in descending order of numbers of
citations in the spreadsheet in Supplementary Table S-3. The
following section examines some of the characteristics of these papers.
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also played important roles in the evolution and advancement of the
ﬁeld.
To highlight the top 100 most-cited papers, these are also shown
in the scatter plot in Supplementary Fig. S-4, where the citation
count for each article number is displayed against its year of publica-
tion; the arbitrary article IDs shown in the ﬁgure correspond to the
numbers that precede each reference listed in Supplementary
Fig. S-4a.
A distribution of the cumulative yearly numbers of the 64most-cited
articles is shown in Supplementary Fig. S-5. From this chart, it can be
seen that the year 2003 has accounted for the greatest number of
these most-cited papers — a total of 10. The fewest were seen in 1998
and 2001.4.6.2.1. The top most-cited articles. There were 13 articles that were each
cited more than 1000 times; the most highly cited articles are among
the most highly cited articles in all of environmental science. These
were published from 1994 to 2006; the four most highly cited articles
had garnered over 2000 citations each and were published in the
narrow window from 1998 to 2002:
Carballa et al., 2004 “Behavior of pharmaceuticals, cosmetics and
hormones in a sewage treatment plant”.
Daughton and Ternes, 1999 “Pharmaceuticals and personal care
products in the environment: Agents of subtle change?”
Desbrow et al., 1998 “Identiﬁcation of estrogenic chemicals in STW
efﬂuent. 1. Chemical Fractionation and in vitro biological screening”.
Fent et al., 2006 “Ecotoxicology of human pharmaceuticals”.
Halling-Sorensen et al., 1998 “Occurrence, fate and effects of
pharmaceutical substances in the environment— A review”.
Heberer, 2002a “Occurrence, fate, and removal of pharmaceutical
residues in the aquatic environment: a review of recent research
data”.
Hirsch et al., 1999 “Occurrence of antibiotics in the aquatic
environment”.
Kolpin et al., 2002 “Pharmaceuticals, hormones, and other organic
wastewater contaminants in U.S. streams, 1999–2000: a national
reconnaissance”.
Purdom et al., 1994 “Estrogenic Effects of Efﬂuents from Sewage
Treatment Works”.
Routledge et al., 1998 “Identiﬁcation of estrogenic chemicals in STW
efﬂuent. 2. in vivo responses in trout and roach”.
Sarmah et al., 2006 “A global perspective on the use, sales, exposure
pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in
the environment”.
Ternes, 1998 “Occurrence of drugs in German sewage treatment
plants and rivers”.
Ternes et al., 1999b “Behaviour and occurrence of estrogens in
municipal sewage treatment plants — I. Investigations in Germany,
Canada and Brazil”.4.6.2.2. Distribution of journals where the 100 most-cited articles on PiE
were published. Of the top 100 most-cited articles on PiE, the majority
of them (62%) were published in just six journals. The remaining 38
top-cited articles were published in 31 different journals and books,
each of which had only one or two top-cited articles:Environmental Science & Technology 24
Water Research 12
Science of the Total Environment 11
Chemosphere 7
Environmental Toxicology and Chemistry 5
Science 3Of the 53 most-highly cited papers, 7 were not published in any of
the 50 journals that have published themajority of the PPCPs literature:
Baquero et al., 2008 “Antibiotics and antibiotic resistance in water
environments”.
Heberer, 2002b “Tracking persistent pharmaceutical residues from
municipal sewage to drinking water”.
Kemper, 2008 “Veterinary antibiotics in the aquatic and terrestrial
environment”.
Kidd et al., 2007 “Collapse of a ﬁsh population after exposure to a
synthetic estrogen”.
Kümmerer, 2004b “Resistance in the environment”.
Richardson and Bowron, 1985 “The fate of pharmaceutical chemicals
in the aquatic environment”.
Snyder et al., 2003 “Pharmaceuticals, Personal Care Products, and
Endocrine Disruptors in Water: Implications for the Water Industry”.
Distribution of most-cited PiE articles among the journals that
published the most articles on PiE.
Of the 386 PiE articles cited at least 200 times, an examination was
made of their distribution among the journals that have published the
most PiE articles. There were 23 journals that had published at least
100 articles each (Table 2); these did not include the two journals
with the highest impact factors (Science and Nature). Together, these
journals contributed 309 of the 386 articles that had been cited at
least 200 times; the remainder of the 386most-cited articleswere inter-
spersed among other journals (atmost 2 per journal). The percentage of
articles receiving at least 200 citations in Science and Nature were
roughly the same as the top 6 journals specializing in environmental
science that had published the most articles. After that, the percentage
of top-cited articles began to decline with certain exceptions.
Those core PiE articles that had had received at least 250 citations
each were primarily distributed among 21 journals; there were 38
journals that had each published a sole article having received at least
250 citations (Supplementary Fig. S-1).
Some of the journals with fewer articles had higher percentages of
most-cited articles (versus total articles published in the respective
journal) than did the six journals with the most total articles (as well
as Science and Nature). These include Environmental Health Perspectives
(5.5%), Environment International (6.9%), and Analytical Chemistry
(10%). Some of the journals that could be considered much more
specialized had very low percentages of highly cited articles, including
Environmental Science and Pollution Research, Chemical Engineering Jour-
nal, and Bioresource Technology, none of which had any highly cited ar-
ticles. Notably, PLoS One had 49 articles, none of whichwas highly cited.4.6.2.3. Incidence of review articles among the 100 most-cited PiE articles.
Review articles (those that provide a synthesis or critical examination
of the published literature) often experience higher citation rates than
original research articles. Indeed, of the top 100 most-cited articles on
PiE, 21 could be considered reviews (either containing theword review
in their titles or abstracts); 12 of these 21 articles were classiﬁed as
reviews by the publishing journal. Of the 21 review articles, ﬁve were
among the top 11 most-cited articles, each with over 1,000 citations.
Of the 100most-cited PiE articles, 21 could be considered reviews of
the literature:
Allen et al., 2010 “Call of the wild: antibiotic resistance genes in
natural environments”.
Boxall et al., 2003 “Are veterinary medicines causing environmental
risks?”
Crisp et al., 1998 “Environmental endocrine disruption: an effects
assessment and analysis”.
Daughton and Ternes, 1999 “Pharmaceuticals and personal care
products in the environment: Agents of subtle change?”
Fent et al., 2006 “Ecotoxicology of human pharmaceuticals”.
Halling-Sorensen et al., 1998 “Occurrence, fate and effects of phar-
maceutical substances in the environment — A review”.
Table 2
The 23 journals that have published the most articles on PiE and their rates for articles cited at least 200 times (compared with PiE articles published in Science and Nature).
Journal Number of papers with more
than 200 citations each
Total number of
papersa
Range of citations per
paper
Percentage of papers that
are highly cited
Science 2 61 454 and 835 3.3
Nature 2 44 249 and 773 4.5
Environmental Science & Technology 73 1074 203–5424 6.8
Chemosphere 33 951 202–2524 3.5
Science of the Total Environment 38 779 202–1577 4.9
Water Research 41 721 202–2142 5.7
Journal of Chromatography A 27 550 201–705 4.9
Environmental Toxicology and Chemistry 18 475 211–640 3.8
Journal of Hazardous Materials 7 398 203–544 1.8
Aquatic Toxicology 9 369 202–1415 2.4
Environmental Science and Pollution Research 0 276 NA 0
Environmental Pollution 8 265 217–380 3.0
Analytical and Bioanalytical Chemistry 4 235 233–334 1.7
Chemical Engineering Journal 0 206 NA 0
Environmental Health Perspectives 10 182 205–3064 5.5
Ecotoxicology and Environmental Safety 3 182 229–450 1.6
Analytica Chimica Acta 2 177 227 and 324 1.1
Water Science & Technology 1 175 257 0.6
Talanta 2 174 469 and 493 1.1
Bioresource Technology 0 133 NA 0
Environment International 9 131 220–625 6.9
Analytical Chemistry 12 120 204–601 10.0
TrAC Trends in Analytical Chemistry 5 111 218–428 4.5
Journal of Agricultural and Food Chemistry 1 111 320 0.9
Journal of Environmental Quality 2 100 246 and 273 2.0
TOTAL 309
a Sorted in descending order of numbers of papers published by each journal.
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residues in the aquatic environment: a review of recent research data”.
Johnson and Sumpter, 2001 “Removal of endocrine-disrupting
chemicals in activated sludge treatment works”.
Kemper, 2008 “Veterinary antibiotics in the aquatic and terrestrial
environment”.
Khetan and Collins, 2007 “Human Pharmaceuticals in the Aquatic
Environment: A Challenge to Green Chemistry”.
Klavarioti et al., 2009 “Removal of residual pharmaceuticals from
aqueous systems by advanced oxidation processes”.
Kümmerer, 2001a “Drugs in the environment: emission of drugs,
diagnostic aids and disinfectants into wastewater by hospitals in
relation to other sources — a review”.
Kümmerer, 2009a “Antibiotics in the aquatic environment — A
review — Part I”.
Kümmerer, 2009b “Antibiotics in the aquatic environment — A
review — Part II”.
Santos et al., 2010 “Ecotoxicological Aspects related to the presence
of Pharmaceuticals in the Aquatic Environment”.
Sarmah et al., 2006 “A global perspective on the use, sales, exposure
pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in
the environment”.
Schwarzenbach et al., 2006 “The challenge of micropollutants in
aquatic systems”.
Thiele-Bruhn, 2003 “Pharmaceutical antibiotic compounds in soils—
a review”.
Tolls, 2001 “Sorption of veterinary pharmaceuticals in soils: A
review”.
Tyler et al., 1998 “EndocrineDisruption inWildlife: A Critical Review
of the Evidence”.
Ying et al., 2002 “Occurrence and fate of hormone steroids in the
environment”.
4.6.2.4. Contributing authors for 100 most-cited PiE articles. The authors
for the 100 most-cited papers (along with the number of these articles
they authored) are shown in Fig. 1. A total of 23 authors each contribut-
ed to 3 or more of these articles; six each contributed to at least ﬁve ar-
ticles (Joss, Kuemmerer, Siegrist, Snyder, Sumpter, and Ternes). Of these23 most-proliﬁc authors of the 100 most-cited papers, 19 did their re-
search in six different European countries (Austria, Denmark,
Germany, Italy, Switzerland, and UK) and four in the U.S. (one of
whom was also from Korea) and Canada.
4.6.2.5. Country afﬁliations of the authors for the earliest, most highly cited
PiE articles. Of the articles with at least 200 citations, 38 (including one
retracted article) were among the earliest works — being published
from 1977 to 1999 (listed in Supplementary Table S-2). The countries
afﬁliatedwith the authors of these 38 articles (with the respective num-
bers of associated articles in parentheses) were: Canada (1), Denmark
(4), Germany (11), Israel (1), Norway (1), Sweden (1), Switzerland
(4), The Netherlands (2), UK (10), and US (7).
4.6.2.6. Technical words occurring most often in the abstracts of the 100
most-cited PiE articles. The word cloud in Fig. 2 shows the technical
words that each occur at least 20 times in the abstracts of the 100
most-cited articles. It shows a very limited number of chemical classes,
therapeutic classes, or speciﬁc APIs are frequently featured: antibiotics,
carbamazepine, cloﬁbric acid, diclofenac, EDCs, estradiol,
ethynylestradiol (EE2), estrogens, estrone, hormones, ibuprofen, and
steroids. The prevalence of steroids certainly reafﬁrms an intersection
of PiE with EDCs. Also revealed is a focus on waste treatment, chemical
monitoring, and risk.
4.6.2.7. Technical words occurring most often in the titles of the 250
most-cited PiE articles. A similar word cloud (Fig. 3) shows the technical
words that each occur at least 5 times in the titles of the 250most-cited
articles. It differs from the abstracts primarily only in the occurrence of
four speciﬁc APIs or classes: ﬂuoroquinolone, sulfonamides, tetracy-
cline, and triclosan.
4.6.2.8. Articles relevant to PiE with authors employed by the US EPA.With
regard to some history behind the U.S. EPA's contributions to the
published literature relevant to PiE, the following record was compiled.
As of 10 December 2015, a total of 283 articles had been published on
PiE-related topics with one or more authors employed by the US EPA.
Nearly 91% of these articles are journal articles or book chapters; 24
Fig. 1.Word Cloud of Authors of Top 100 Cited Articles (as of 21 May 15).
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1975 but only nine of them predate 2000. Nine of these EPA-authored
articles are among the larger group of 386 most-cited PiE articles. Each
of these nine articles (indicated in the on-line listing) had citations
counts ranging from 253 to 3064. A complete list of these articles can
be accessed on-line here: https://sites.google.com/site/daughton/
PPCPs-bibliographic_database.
4.6.2.9. PiE articles that have been retracted or withdrawn. Over the last
couple of decades, interest and concern have been growingwith respect
to ethics in the conduct and publishing of science. The incidence of vol-
untary and mandated retractions and withdrawals of published papers
has been escalating since the 2000s; the ﬁrst attempt to follow retrac-
tions across science began in 2010 with the start of the on-line blog
retractionwatch.com. An examination of the PPCPs database indicates
that the incidence of retractions for PiE-related articles may be rather
low. A total of 11 articles relevant to PiE had been retracted (as of 5
October 2015):
Arnold et al., 1996 “≪RETRACTED≫ Synergistic activation
of estrogen receptor with combinations of environmental
chemicals”.
Blanco et al., 2007 “≪RETRACTED≫ Geographical variation in
cloacal microﬂora and bacterial antibiotic resistance in a threatened
avian scavenger in relation to diet and livestock farming practices”.Fig. 2.Word Cloud of Abstracts of Top 100Blanco and Lemus, 2010 “Livestock Drugs and Disease: The Fatal
Combination behind Breeding Failure in Endangered Bearded Vultures
≪RETRACTED≫”.
Blanco et al., 2009a “≪RETRACTED≫Microbial pollution in wildlife:
Linking agricultural manuring and bacterial antibiotic resistance in
red-billed choughs”.
Blanco et al., 2009b “≪RETRACTED≫ Ingestion of multiple
veterinary drugs and associated impact on vulture health: implications
of livestock carcass elimination practices”.
Lemus and Blanco, 2009 “≪RETRACTED≫ Cellular and humoral
immunodepression in vultures feeding upon medicated livestock
carrion”.
Lemus et al., 2008 “≪RETRACTED≫ Antibiotics threaten wildlife:
circulating quinolone residues and disease in Avian scavengers”.
Liu et al., 2012 “≪RETRACTED≫ Degradation of polycyclic musk
HHCB in water by O3, UV, and UV/O3”.
McLachlan, 1997 “≪RETRACTED≫ Synergistic Effect of
Environmental Estrogens”.
Mohammedet al., 2013 “≪RETRACTED≫ Fate and Transport of EDCs
in Soils: Estrone and Its Sulfate Conjugate's Adsorption from Mediator
Solutions”.
Oropesa et al., 2012 “≪RETRACTED≫ Acute and chronic toxicity of
the pharmaceutical levonorgestrel to the freshwater crustacean
Daphnia magna”.Cited PiE Articles (as of 20 May 15).
Fig. 3.Word Cloud of Titles of Articles Cited at Least 250 times (as of 14 May 15).
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have been retracted by the same author (Lemus), whose works have
been followed by retractionwatch.com (http://retractionwatch.com/
category/jesus-angel-lemus/); another author (McLachlan) had two
retracted papers, both published in Science. Some of these articles had
been cited by others - even years after the retractions. This is because
retraction notices can be very time consuming to locate, especially
since searches must be conducted on an ongoing basis. There is no
standard or accepted practice for how publishers handle the posting of
retraction notices. An article by Arnold et al. (1996) has become highly
cited (621 citations) and continues to receive citations. This is partly be-
cause its retraction became a distracting set-back for the ﬁeld of EDCs.
Other retracted PiE articles have also received citations, sometimes
years after retraction: Blanco et al., 2009b (46 citations), Lemus et al.,
2008 (69), and McLachlan, 1997 (132).5. Closing thoughts
Amajor lesson from this project was the degree of difﬁculty in com-
piling comprehensive data on citation frequencies for individual articles
and the inordinate time that was required. This was particularly true for
un-cited articles, which – surprisingly – are far more difﬁcult to locate
than highly cited articles; this difﬁculty undoubtedly is a factor that
contributes to extending the time over which these articles remain
un-cited. But it is also surprisingly difﬁcult to locate those articles that
composed the top-cited tier, as there are many steps required to ensure
comprehensive coverage. These seemingly simple facts lead to the
following question. Could ready and free access to meta-data (such as
citation frequencies) for all of the published works that comprise PiE
(or any other ﬁeld of research) serve to facilitate the advancement of
the ﬁeld?
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jargon in the literature is also quite difﬁcult. It is also more difﬁcult to
ensure comprehensive scrutiny of the literature. This is the result of
major obstacles. First is that the older literature is farmore difﬁcult to lo-
cate and acquire – especially in full-text form. Second, most of the older
articles must be converted to digital formats to permit searching; but
optical character recognition can have a high error rate with poor im-
ages. This reduces the effectiveness of full-text searching. And third, it
is unknown how much of the older literature is simply not accessible
on-line. For the topic of PiE, it is likely that a signiﬁcant number of rele-
vant articles exist in non-English journals, especially German, Dutch,
and Danish. This means that the dates provided for the emergence of
many of the terms tracked in this paper could be earlier than noted.
PiE is clearly a remarkably interdisciplinary research area. Its expan-
sive scope poses obvious challenges for researchers across numerous
disciplines. One obvious challenge rests in the sheer size of the pub-
lished literature. At the same time, PiE's cross-cutting nature – and its
close association with allied topics such as EDCs and emerging contam-
inants –means that the potential is high for many beneﬁcial collateral
outcomes. Resources devoted to PiE can also serve to catalyze advance-
ments for a host of other important topics, not the least of which in-
clude: engineered treatment of wastewater and drinking water; water
reuse (with an increased imperative imposed by climate change,
drought, and aging infrastructures); the toxicological concerns sur-
rounding low-dose exposure and simultaneous/sequential exposure to
multiple chemical stressors; the sustainable and prudent use of drugs
(especially antibiotics - for both human and veterinary use — and
those drugs with high acute toxicity); and environmental stewardship
and pollution prevention for reducing API entry to the environment.
The proliferation of papers on the many facets of the PiE topic poses
a very important questionwith respect to the future of how science pro-
gresses. As withmany ﬁelds of investigation, it is clearly not possible for
anyone to keep up with its rapidly growing body of published works. It
may not even be possible to keep current with single, narrower facets of
the larger topic (such aswaste treatment or biological effects). Immedi-
ate concerns emerge as to the knowledge content and impact of this
body of work. In what ways and to what degrees is our understanding
of the PiE ﬁeld being advanced? Does the investment in time and
resources that underlie these escalating numbers of articles lead to
commensurate beneﬁts to the science community and society? Of
course, this presupposes that these impacts can even be identiﬁed and
measured. Is it possible to identify the most important areas for future
research and to guide allocation of resources in these directions?
These concerns conﬂict with the competing importance of quickly
identifying previously unrecognized or poorly appreciated (emerging)
concerns — the type of research that often requires ignoring what has
been previously examined.
As an example relating to impact, it is interesting to examine the
PPCPs database for journal articles on PiE that have never been cited
or have been very infrequently cited. This includes articles that are 2–
3 years old that have never been cited and older articles that have
been cited at most 5 times. Among the 15,000 journal articles, these in-
frequently cited articles currently total over 340, representing over 2% of
the database. This prompts the obvious questions as to the possible
cause(s) for papers that are rarely cited, including: journal accessibility,
perceptions of poor quality by potential citing papers, or the contribu-
tion is perceived as redundantwith prior publishedworks or as not con-
tributing to advancement of theﬁeld. Also possibly atwork is the impact
of cognitive bias from the Matthew Effect, which serves to perpetuate
the citation of articles that have already garnered the most citations
while simultaneously fostering continued disinterest in those articles
that have yet to the cited (Daughton, 2014c “The Matthew Effect and
widely prescribed pharmaceuticals lacking environmental monitoring:
Case study of an exposure-assessment vulnerability”).
These questions, andmany others, relate to the efﬁciency of science.
Does the sheer size of the published literature, regardless of its quality,serve as overwhelming noise that obliterates what would ordinarily
be useful? The question at hand is whether the long-establish way in
whichnewknowledge is conveyed –namely, thepeer-reviewed journal
article – can be radically altered to enhance theway inwhichuseful data
and knowledge can be mined. The only aspect of the published litera-
ture (which comprises ever-growing numbers of articles as well as
journals themselves) that serves to weakly organize or unify it is the
practice of cross citation. And the practice of citation can only be exam-
ined by means of time-consuming and exhaustive citation analysis,
which attempts to reveal the loose networks of citing and cited articles.
The larger question is whether the practice of communicating the
ﬁndings of research via the conventional published article can be re-
placedwith amore efﬁcientmodel that serves, in part, to reduce the du-
plication of effort, minimize research that might add only marginally to
a ﬁeld, and instead help focus on the top priorities. What the priorities
might be for PiE – and how they might be established – are themselves
challenging questions; the following serve as examples:
Berninger et al., 2015 “Prioritization of pharmaceuticals for potential
environmental hazard through leveraging a large scale mammalian
pharmacological dataset”.
Rudd et al., 2014 “International scientists' priorities for research on
pharmaceuticals and personal care products in the environment”.
The challenge of a more efﬁcient model for communication is partly
being addressed by the rapidly evolving but still rather vague concept of
collaborative science, dubbed Science 2.0 (e.g., see: https://en.
wikipedia.org/wiki/Science_2.0). Regardless of what that future might
look like, a transformation needs to involve a much more efﬁcient way
of locating and distilling existing data from the conventional published
literature and for formulating new knowledge and insights that can bet-
ter guide and accelerate the trajectory of a highly complex ﬁeld of study
such as PiE — enhancing its value to society.
EPA notice
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